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The European Union has adopted recently an ambitious 
strategy for developing the Bioeconomy in Europe. The 
bioeconomy is based on the innovative use of sustainable 
biological resources to cover the growing demand of the 
food, energy and industrial sectors. In this context, algae 
represents an emerging biological resource of great 
importance for its potential applications in different fields, 
including food and feed.
The waters of the world host a large variety of organisms 
which are able to use light as source of energy to fuel their 
metabolism. Within these organisms, algae are a group 
of relatively simple, plant-like organisms, most of which 
capable of performing photosynthesis. Algae size ranges 
from micrometres of unicellular micro-algae to macro-algal 
seaweeds of tens of metres. Algae contain several high-value 
molecules, such as lipids (oil), proteins and carbohydrates 
(sugars), and for this reason there is a growing interest in 
algae as production organisms.
Algae, especially marine algae, have been already used 
as food, feed and fertilizers for centuries, and nowadays 
approximately 200 species are used worldwide in different 
sectors. Recently, algae have been used for the production 
of ethanol or biodiesel and research is on-going on genetic 
engineering of micro-algae, especially for the production 
of pharmaceuticals and cosmetics. However, no genetically 
modified micro-algae are currently on the market.
This report presents the results of an analysis of the 
technological and market developments in the field of 
micro-algal production systems, especially for food and feed 
products. Based on literature search and on interviews and 
survey to experts, the report provides the current state-of-
the-art of microalgae as systems for producing food/feed 
products and discusses the future challenges for Europe to 
become a key player in this field.
The production systems of micro-algae may vary from open-
air ponds to closed systems such as photo-bio-reactors. 
While open-air ponds present a great dependence on weather 
conditions, a high risk of contamination and an elevated 
consumption of water, they have low construction costs and 
require easy maintenance. On the other side, closed systems 
present higher costs but also higher production efficiency. 
Extraction expenses come on top of all costs for microalgae-
derived products.
The global market for micro-algae-based food and feed 
supplements/nutraceuticals is well developed and with a 
great potential for growth. Micro-algae are currently used 
both as dried whole algae and for the extraction of high-
value food/feed supplements and colorants. Although the 
total production volumes and market size of food and 
feed supplements/nutraceuticals derived from micro-
algae are still relatively small with respect to alternative 
sources, they have increased 5-fold since the beginning of 
the century, and now some micro-algae applications have 
already a long tradition. On the other hand, the large-scale 
commercial production of microalgae as a source of protein/
carbohydrates with impact on food-feed security can still be 
considered an infant industry.
Spirulina and Chlorella dietary supplements used as dried 
whole algae have by far the largest production volumes 
worldwide (5,000 and 2,000 tons of dry matter/year 
respectively), with an estimated global production values of 
about $40 Millions/year each. On the other hand, micro-algae-
based high-value molecules (such as astaxanthin, omega-3 
fatty acids and β-carotene) have smaller production volumes 
but larger market potential. For example, the production 
volumes of poly-unsaturated fatty acids (DHA/EPA) from 
micro-algae are only 240 tons/year, but the market value 
of this production (mostly extracted from ocean fish) is 
estimated to be higher than $300 Million/year. Therefore, 
microalgae are becoming a sustainable alternative for the 
production of these products. In the future, micro-algae 
based proteins and oils will also become available as food 
ingredients.
At present, the low volumes and high production costs 
of microalgae encourage exclusively the production of 
high-value supplements and nutraceuticals for human 
consumption. The microalgae-based molecules have specific 
advantages with respect to their synthetic and traditional 
alternatives that makes their use commercially viable for 
the food sector compared to the corresponding alternatives, 
despite the higher production costs. The higher quality of 
microalgae-based molecules compared to the corresponding 
alternatives is mainly due to their chemical conformation 
that is much more effective for food applications than 
the syntetic variants. However, the bulk production of 
carbohydrates and proteins for the food and feed sector is 
not yet forseen in the short run, because it would require 
higher production volumes and, consequently, the boosting 
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of the cost effective scale-up with dramatic reduction of 
production costs. For these reasons, the actual contribution 
of microalgae-based food and feed products to global and 
European food security is rather limited.
The production of micro-algae is currently concentrated 
in a small number of producers, except for Chlorella. Most 
producers are located in Asia or Australia, but recently 
some European firms have acquired a number of leading 
companies in Australia and in the United States. The 
production of microalgae-based food and feed products 
from European firms is currently estimated at around 5% 
of the global market. Additionally, according to the analysis 
of pipeline products, many European producers are stepping 
into the micro-algae-based high-value molecules markets.
Most experts consulted estimate that Europe can become 
market leader in micro-algae based products for the food 
and feed markets in the next decade. The two most important 
factors that may contribute to the expected European market 
position are scientific and technological developments in 
the field of micro-algae research and in the food and feed 
market. However, experts highlight two major factors limiting 
the European potential: the insufficient European domestic 
demand for these products and the difficulties in achieving 
commercial authorization of algae-derived products in the 
EU markets due to the complexity of the regulation of novel 
foods in Europe. Hence, new microalgae-based products 
obtained in Europe may be intended mainly for foreign 
markets, and the increased production share by European 
companies will be mainly a result of strategic acquisitions of 
foreign companies.
An important source of innovation in microalgae production 
systems will come from biotechnology. Research on algae 
and genetic modification of algae is rapidly expanding due 
to high expectation with respect to the production of biofuel, 
bio-chemicals and other bio-products by algae. Large 
investments from governments and industries stimulate 
the research on GM algae. However, the technology is still 
immature and further research and development is needed 
before commercial production of products from GM algae 
will take place.
With respect to the potential risks of microalgae-based food 
products and their management, full knowledge about the 
possible production of toxins, allergens or other harmful 
compounds by the algae strain(s) that are used in industrial 
production is of utmost importance. For that reason, strain 
identity is an important parameter for determining the 
potential risk of mass cultivation of industrial algae.
This report illustrates the regulations applied to the 
commercial introduction of microalgae-based food products 
in two of the main global markets: the EU and the USA, 
which differe substantially both in the approach and in the 
requirements for their regulations on micro-algae products. 
One of the main differences between the European and USA 
regulation concerns the criteria for defining novel food and, 
consequently, the corresponding authorisation procedures. 
Moreover, the differences on the GMO regulation between 
US (based on the characteristics of the final product) and 
the EU (based on the technology employed to obtain the 
final product) may affect the future developments of algae 
biotechnology. 
In conclusion, Europe presents important strengths in the 
field of micro-algae applications. Its strong position in science 
and technology, related to the high priority in R&D funding 
policies, makes Europe very active in this area. Moreover, 
Europe has specific structural economic and logistical 
assets that enhance its position in micro-algae research and 
applications. Europe has an outstanding tradition in high-
quality agriculture production and a strong food and feed 
industry with multinationals operating on the global scale. 
Europe also benefits from high levels of human capital, 
workforce with adequate engineering and technical skills to 
work in micro-algae research, development and applications. 
Moreover, the spill-over effects from research on micro-algae 
for the biofuel sector and for sustainable production of food, 
are likely to contribute to the improvement of the European 
competitiveness in the micro-algae sector in the near future.
On the other side, some weaknesses of the European 
microalgae sector may hinder its competitiveness. Europe’s 
main weaknesses are its relatively suboptimal climatic 
conditions with high levels of rainfall, low levels of sun hours 
and intensity (especially in winter) and low temperatures for 
most countries outside southern Europe. For these reasons, 
Europe lacks of optimal surface areas for the production of 
micro-algae. Moreover, Europe has some structural financial-
economic disadvantages: relatively high labour costs, lack of 
venture capital and seed capital for start-up companies, low 
entrepreneurial activity among researchers and engineers, 
low R&D investments by large companies, high land costs 
and low internal demand for microalgae-based food and 
feed products.
I n t r o d u c t i o n
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1.1 Growing importance of 
micro-algae as source of food 
and feed
The waters of the world, oceans, seas, rivers, creeks, lakes 
and even ice, host a large variety of organisms which are 
able to use light as the only energy source for their metabolic 
processes. Algae are a group of relatively simple, plant-
like organisms, most of which are capable of performing 
photosynthesis: They capture light and use its energy to 
convert CO2 into sugars and oxygen. In this way, they largely 
contribute to the global oxygen production (between 50 to 
87 per cent). There are 80,000 to 100,000 different algae 
species with widely varying characteristics; many of which 
have been investigated. Algae size ranges from micrometres 
of unicellular micro-algae to macro-algae seaweeds of tens 
of metres. The organisms considered in this report are micro-
algae growing in aquatic environments.
Globally, there is growing interest in algae as production 
organisms. Algae contain lipids (oil), proteins and 
carbohydrates (sugars), and, especially marine algae 
have been used as food, feed and fertilisers for centuries. 
Commercial farming of macro-algae (seaweeds) has a 
long history, especially in Asia. In the 1950s algae were 
considered a candidate for protein supply for the increasing 
world population. In 1950s on, a search for biologically 
active substances from algae began. Commercial large-
scale cultures of the micro-algae species Chlorella were 
started in the early 1960s followed by Arthrospira (Spirulina) 
in the 1970s. 
Since 1980, large-scale micro-algae production facilities 
were established in Asia, India, the USA, Israel and Australia. 
Nowadays approximately 200 species of micro-algae are 
used worldwide. There is a well-established global market 
for micro-algae based food and feed products, but micro-
algae also have other functions. More recently algae are 
used for the production of ethanol (fermentation) or biodiesel 
(conversion) and research using GM algae for the production 
of pharmaceuticals is currently on-going.
The use of micro-algae for the food and feed market is 
increasingly relevant as the components of micro-algae 
(such as fatty acids, colourants, vitamins) have the potential 
to be competitive with the same components from other 
sources. To develop the competitiveness of micro-algae 
based products, not only the technical and the economic 
aspects are important, but also the national regulations 
ruling their use play a fundamental role.
The goal of this study is to analyse:
• The current status of micro-algae production systems for 
different species and products, describing the most suited 
for food and feed applications;
• The market applications of micro-algae for food and 
feed;The state-of-the-art of research and development on 
micro-algae biotechnology and genetic engineering; 
• An overview of risks, risk management and regulatory 
frameworks governing micro-algae research, production 
and commercialisation, providing a comparison between 
the EU and the USA.
Finally, the study provides a critical analysis of the EU-
specific strengths and weaknesses in the development of 
commercial micro-algae products and production systems.
1.2 Methodology
This report presents the results of a study on the scientific 
and economic developments in the field of microalgae-
based products for food and feed. It provides the current 
state-of-the-art and new insights on five topics concerning 
the European micro-algae sector. The topics under study are 
the following:
1. Production systems;
2. Economics of micro-algae products and production;
3. Biotechnology and genetic modification;
4. Risks and risk management; 
5. Regulation.
The methodology applied is structured into three steps: 1) 
literature review; 2) experts interviews; and 3) experts Delphi 
1. Introduction
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survey. In Annex A the full detailes of the methodology 
adopted in each step are illustrated.
This report presents the results of the whole study, 
integrating the findings from the literature review, the 
interviews and the Delphi survey. The results of the experts 
interviews have been integrated with the findings of the 
literature review for each of the five topics analysed and 
are presented in chapters. Most of the results of the Delphi 
survey are presented in Chapter 3, while the results on the 
European position in micro-algae research and production 
are discussed in the final chapter. 
1.3 Content of the report
The remainder of the report is structured as follows: the 
next chapter (Chapter 2) provides an overview of the current 
status of micro-algae production systems for different 
species and products. Chapter 3 addresses the economic 
aspects - the current and future situation of micro-algal 
products, their producers and the economic aspects of 
the production processes - and presents the results of 
the survey. Chapter 4 presents the state-of-the-art of 
research and development on micro-algae products with a 
particular focus on biotechnology and genetic engineering. 
Chapter 5 contains an up-to-date overview of risks and risk 
management of micro-algae and presents the European 
and USA regulations concerning algae production and GM 
algae research, production and market introduction. The 
last chapter concludes this report with the findings on the 
future EU-specific strengths and weaknesses to develop 
commercial micro-algae production systems for food and 
feed applications.
M i c r o - a l g a l  p r o d u c t i o n  s y s t e m s
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This chapter focuses on the current status of micro-algae 
production systems for those species and products that 
are most suited for feed and/or food applications. The first 
section (2.1) introduces micro-algae and the most used 
species in research and production. Section 2.2 presents the 
open systems, Section 2.3 the closed systems, Section 2.4 
the indoor production systems and Section 2.5 illustrates the 
usual growth conditions applied for algae. The chapter closes 
with the main conclusions (2.6).
2.1 Species used in micro-algae 
research and production
The three most important classes of micro-algae in 
terms of abundance are the diatoms (Bacillariophyceae), 
the green algae (Chlorophyceae), and the golden algae 
(Chrysophyceae). All these micro-algae are eukaryotes 
distinguished by the presence of a nucleus and separate 
organelles for photosynthesis (chloroplasts) and respiration 
(mitochondria). In this report, cyanobacteria (Cyanophyceae 
or blue-green algae) are also referred to as micro-algae, 
e.g. the species Spirulina (Arthrospira platensis and A. 
maxima). The cyanobacteria are part of the eubacteria and 
are prokaryotes lacking a membrane-bounded nucleus. 
There are thousands of different species of micro-algae and 
cyanobacteria.
Diatoms are the dominant life form in phytoplankton and 
probably represent the largest group of biomass producers 
on earth. It is estimated that more than 100,000 species 
exist. The cell walls of diatoms contain polymerised silica, 
and they often accumulate oils and chrysolaminarin (a 
storage polysaccharide). 
Green algae are especially abundant in fresh water. The 
main storage compound of green algae is starch, although 
oils can also be produced. The fresh water green algae 
Haematococcus pluvialis is commercially important as a 
source of astaxanthin, Chlorella vulgaris as a supplementary 
food product or food ingredient and the halophilic algae 
species Dunaliella as a source of β-carotene. 
The golden algae also produce oils and carbohydrates and 
are in this respect similar to diatoms. The blue-green algae 
(Cyanobacteria) are found in a variety of habitats and several 
of them are known for their water polluting effect due to the 
production of toxins. 
Most algae are autotrophs, while some are heterotrophic. 
An autotroph is an organism that produces complex organic 
compounds (such as carbohydrates, fats, and proteins) from 
simple substances present in its surroundings. Autotrophs 
can be phototrophs or chemotrophs, depending if they use 
light as energy source (photosynthesis), or electron donors 
from organic or inorganic sources (chemosynthesis). A 
heterotroph is an organism that cannot fix carbon and 
therefore needs organic carbon for its growth. Mixotrophic 
algae can use both sunlight or organic carbon. 
Currently, the most used phototrophic species are 
Arthrospira (Spirulina, blue green algae), Chlorella, Dunaliella 
and Haematocussus which can be grown with (sun)light 
as energy source. Furthermore, with emphasis on the 
production of omega-3 fatty acids, heterotrophic marine 
organisms Crypthecodinium, Schizochytrium and Ulkenia 
are cultivated, similarly to  yeasts, in indoor, well controlled 
vessels with the addition of sugars or other carbon sources 
but without sunlight. For some applications Chlorella 
species are cultivated also as heterotrophic algae. For fish 
aquaculture (mainly to feed the larvae) the main cultivated 
species are: Chlorella, Isochrysis, Pavlova, Phaeodactylum, 
Chaetoceros, Nannochloropsis, Skeletonema, Thalassiosira, 
Haematococcus, Tetraselmis. 
Micro-algae represent potential feedstock for food and feed. 
However, the technology for the production of micro-algae is 
still immature. Research and development has been done in 
recent years and continues on cultivation systems. A leap in 
the development of micro-algae technology is required; on a 
practical level, the scale of production needs to increase with 
a concomitant decrease in the cost of production. 
Micro-algae are cultivated in a wide range of different 
cultivation systems that can be placed outdoors or indoors. 
Cultivation systems range from open shallow raceway ponds 
to closed photobioreactors (Figure 1). The systems mostly 
used on a large scale and on a commercial basis are open 
systems (Figure 2).
2. Micro-algal production systems
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2.1.1 Open systems 
The most common open systems for micro-algae production 
are ponds. These ponds are usually no more than 30 cm1 
deep. The circulation of the water with nutrients and micro-
algae is done by a mechanical arm stirring in a circular motion 
in circular ponds (Centre-Pivot ponds), or more commonly by 
a paddle wheel in so-called raceway ponds. CO2 or exhaust 
or flue gases containing CO2 can be sprayed in the culture. 
Major weaknesses of open systems are that there is almost 
no possibility for temperature control (unless a source 
of cheap surplus heat is available). Also they are very 
1 A certain minimal depth is needed to keep the liquid flowing through the canals 
using the paddle wheels.
susceptible to invasion of algal predators, parasitic algae or 
other algal strains that grow faster at the applied conditions 
and therefore out-compete the desired species. Only a few 
species can be grown in these systems either by applying a 
selective environment, e.g. high salinity for Dunaliella salina 
and high alkalinity for Spirulina platensis, or by making 
use of large amounts of inoculum produced under strictly 
controlled conditions and taking advantage of fast-growing 
species such as Chlorella. Moreover, biomass concentration 
and thus volumetric productivity is very low due to the long 
light path, and poor mixing.
Figure 1  Algae production systems at the research facility AlgaePARC, Wageningen UR NL
A. Open pond system. B. Horizontal tubular system. C. Flat Panel system (ProviAPT). D. Vertical tubular system
Source: Wageningen UR
A
C
B
D
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For mixing and circulation, a paddle wheel (Figure 2b) is 
used. The paddle wheel operates continuously to prevent 
sedimentation, to avoid the formation of a temperature 
gradient, for the distribution of nutrients and carbon dioxide, 
for removal of produced oxygen and for transporting algae 
from and to the surface, which improves the total light 
utilisation efficiency [4]. The power required for mixing 
increases dramatically with flow speed. 
The temperature in an open raceway fluctuates within a 
diurnal cycle and seasonally. Temperature is very difficult 
to control. Cooling can occur by means of evaporation. 
Evaporative water loss can be significant and causes an 
increase in concentration of salt and other compounds [5]. This 
could be counteracted by re-supplying water of sufficiently 
low salt content, although this may be problematic at some 
geographic locations. While saline groundwater is unsuitable 
for agriculture, it could be employed in some alga cultures. 
Besides sunlight, other options for heating are the use of 
warm wastewater or surplus heat from power generation or 
industry. 
Due to significant losses to atmosphere, raceways - as in 
other open systems - use carbon dioxide much less efficiently 
than closed photobioreactors [5]. 
Nutrients are added to the water stream that is used to 
replace the micro-algae culture which is (semi) continuously 
Figure 2  Example of open pond systems
Open systems a ) Small pond for Spirulina culture, Asia [2]; b) CentrePivot ponds for the culture of Chlorella in Yaiwan [3]; c) Dunaliella salina ponds of 
Cognis, Western Australia [3]; d) Raceway pond for production of Dunaliella bardawil at Nikken Sohansha Corporation in Eilat, Israel. Source: Wageningen UR.
On average, the biomass productivity in open systems is ca 
30 tonnes of dry biomass/ha/year (value for solar conditions 
found in South Europe).
Open systems have already been used for commercial algae 
cultivation for decades. In Hawaii for instance the company 
Cyanotech is growing Spirulina and Haematococcus on 90 
acres (3.6 hectare).
2.1.2 Raceway Ponds
A raceway pond is a specific form of open system built as a 
shallow closed loop channel that allows the water to circulate 
(Figure 2d). Raceway ponds are easy to build and, for this 
reason, they are the most common cultivation systems for 
the commercial production of micro-algae. 
Raceway ponds are commonly built in concrete or compacted 
earth. Their shape may vary, but for a large area with 
multiple raceways, long stretched ponds with 180° curves 
on either end are the most compact and efficient. Raceways 
may be lined with plastic which allows thorough cleaning 
to remove contaminating organisms; it is assumed that this 
will increase the life-expectancy of the system and allow for 
easier maintenance. The materials chosen for construction 
should provide sufficient water retention.
A
C
B
D
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harvested. Considering a typical depth of 30 cm , these 
systems are very voluminous and the micro-algae biomass 
concentration in these ponds is low, in the order of 0.1 to 
0.5 g·L 1.
Productivity is affected by contamination with unwanted 
algae and micro-organisms that feed on algae [5]. Other 
species can outcompete the desired strain. 
Raceway ponds are used for the cultivation of micro-algae 
or cyanobacteria with Arthrospira (Spirulina) platensis, 
Dunaliella salina and different Chlorella species being the 
most important.
In the Netherlands, raceway ponds were used by Ingrepro at 
Borculo (this company recently went bankrupt), by AquaPhyto 
at Zeewolde and Schiphol Airport (this company no longer 
exists), and by Kellstein Greencircle at Hallum. In addition, 
a raceway pond system is present at the AlgaePARC, a pilot 
research facility of Wageningen UR. In France there are also 
raceway ponds in Activ’Alg (www.activalg.fr) and Algosource 
Technologies (www.algosource.com). In Italy, the company 
Eni (www.eni.com) is using raceway ponds to fix CO2 from 
a power plant. Companies in Europe mostly use closed 
systems.
2.2 Closed systems 
There is a large variety of closed systems used for the 
production of algae. These closed systems prevent contact 
between the enclosed algae and the environment. For 
sampling and harvesting, precautions can be taken in order 
to limit the contact with the environment. Tubular systems 
of different sizes (placed either vertically or horizontally), 
polyethylene sleeves or bags and flat panels are most 
commonly used, but there are also new designs like biodomes 
and even floating bags on ocean waters. However, accidents 
or careless handling may breach the containment of these 
systems.
Closed systems are typically referred to as photobioreactors 
(PBRs). They can be placed outdoors but in some cases they 
are placed inside greenhouses to allow more controlled 
conditions at the expense of higher production costs. 
Photobioreactors are considered to have several major 
advantages over open ponds, they can:
• Prevent or minimise contamination, allowing the cultivation 
of algal species that cannot be grown in open ponds;
• Offer better control over cultivation conditions (pH, pCO2, 
pO2, temperature, nutrient supply, etc);
• Prevent evaporation and reduce water use;
• Lower CO2 losses due to outgassing;
• Attain higher cell concentration and therefore higher 
volumetric productivity.
The costs of installation and operation of photobioreactors, 
however, is much higher than those of open pond systems.
2.2.1 Design criteria
Design criteria for photobioreactors should aim at achieving 
high efficiency of light conversion and at providing the 
necessary reliability and stability to the cultivation 
process by solving the main problems encountered in 
photobioreactor operations such as overheating, oxygen 
build-up and biofouling. The fundamental design criteria for 
photobioreactors include reactor configuration in respect to 
light gradient and light/dark cycles, surface to volume ratio, 
mixing and degassing devices.
Surface-to-volume ratio
The surface-to-volume (S/V) ratio of the bioreactor, (i.e. the 
ratio between the illuminated surface of the reactor and 
its volume) determines the amount of light that enters the 
system per unit volume and the light regimen to which the 
cell population is exposed, and is consequently one of the 
most important issues in photobioreactor design. The higher 
the S/V ratio, the higher is the cell concentration at which 
the reactor is operated and the volumetric productivity of 
the culture. The hydrodynamic behaviour of the culture is 
also affected by this parameter: higher S/V ratios can lead to 
shorter light/dark cycles. For these reasons, in recent years 
a general trend towards the reduction of the diameter of 
tubular reactors and the thickness of flat panels can be seen.
Mixing
The type of device used to mix and circulate the culture 
suspension is essential in the design of a successful 
photobioreactor. Both the productivity of a photobioreactor 
and the cost of its construction and operation are influenced 
to a great extent by the type of device used for mixing. 
Mixing is necessary to:
• Prevent cells from settling;
• Avoid pH and temperature gradients along the reactor;
• Distribute nutrients;
• Remove photosynthetically generated oxygen, which after 
a certain value inhibits photosynthesis;
• Supply CO2;
• Ensure that all cells experience alternating periods of light 
and darkness.
Yet, it must be pointed out that excessive mixing can lead 
to cell damage and eventually cell death. For this reason 
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the choice of mixing intensity and mixing system must 
be dictated by the characteristics of the organism to be 
cultivated.
2.2.2 Main photobioreactors characteristics 
The use of photobioreactors results in lower space 
requirements and lower harvesting costs per ton algae, 
compared to open systems. Most designs are based on the 
principles related to tubular photobioreactors and flat panels. 
Scalability of these systems is however still only possible by 
increasing the number of modules.
The main inputs required in addition to the algae themselves 
are sunlight, water, CO2, nitrogen and phosphorus. Large-
scale cultivation of micro-algae for low/medium value 
products must be based on sunlight as the sole source of 
light energy.
When working in summertime, and/or at lower latitudes, 
sunlight intensities are high and often oversaturate the 
photosynthetic cycle, limiting algae growth and leading to a 
drop in productivity. In recent years, much effort was put into 
increasing photosynthetic efficiency of micro-algae under 
oversaturating light (the normal condition on a sunny day) 
by developing new strains with smaller antenna sizes [8] 
and by decreasing the light path of photobioreactors while 
increasing mixing (turbulence) in high cell density cultures 
[9, 10]. Turbulence requires high-energy input and therefore 
is not suitable for large-scale production of biofuels from 
micro-algae. 
One strategy to obtain high photosynthetic efficiencies under 
bright sunlight in systems with lower energy requirements 
is to reduce the light intensity at the reactor surface. This 
can be done by stacking the reactor units vertically. Narrow 
spacing in the stacks minimises loss of light to the ground 
surface [9]. However, if not combined with a short light path, 
this setup leads to voluminous reactor systems with low 
volumetric productivity and low biomass concentration [11]. 
In order to reduce investment costs of these systems, 
vertical panels can be made from thin plastic films such 
as polyethylene. There are examples of thin film systems 
submerged in large water volumes for good temperature 
control and a lower associated energy requirement for 
cooling [12]. We expect that in the coming years many 
systems will be developed based on these design principles. 
Improvements are to be expected in material lifetime 
(polyethylene has a lifetime of ~1 year), ease of cleaning, and 
energy requirements (for example, the energy requirement 
for cooling can be further reduced by reflecting the near-
infrared portion of the light incident on the reactor surface, 
which otherwise heats the system without contributing to 
photosynthesis) [13].
2.2.3 Tubular photobioreactors
Tubular photobioreactors are based on transparent tubes 
in which the algae culture is maintained and exposed to 
sunlight (Figure 3). Although not visible, a large number of 
tubes are connected to each other via manifolds and the 
liquid is continuously pumped through the tubes (Figure 4). 
This has to be done for two reasons. One reason is to prevent 
the micro-algae cells from settling and to have the cells 
continuously moving from the sunlight-exposed tube surface 
to the darker zones in the centre of the tubes. The other 
reason is related to the accumulation of oxygen in micro-
algae cultures. As in any other cultivation system oxygen will 
quickly accumulate because of photosynthesis. 
Given the low solubility of oxygen in water, the oxygen 
partial pressure will quickly rise to levels way above those in 
equilibrium with air. For this reason the micro-algae culture 
is continuously pumped through a so-called degassing 
vessel where the oxygen is allowed to escape. Within this 
vessel oxygen degassing is usually enhanced by aerating the 
degassing vessel with finely dispersed air bubbles. Obviously 
the length of the tubes and the liquid velocity in the tubes 
are important design parameters. Typical numbers are 50 
to 100 m for tube length and 0.2 to 0.5 m·s-1 for the liquid 
flow velocity.
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Figure 3  Tubular photobioreactors
On the left (a) a horizontal tubular system based on thin flexible plastic tubes in southern Spain. This system has been designed by the Dutch com-
pany Paques in collaboration with Bioprocess Engineering of WU. On the right (b) a vertical fence type structure based on rigid glass or plastic tubes 
placed in a greenhouse in Germany. This system was designed by the German research institute IGV. Source: Wageningen UR.
A B
Figure 4  Simplified scheme of a horizontal tubular photobioreactor
Source: Wageningen UR.
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2.2.4 Vertical panel photobioreactors
Vertical panel photobioreactors are composed of thin 
rectangular cultivation vessels with a depth in the range 
of 0.01 to 0.10 m. They are mixed by gassing the panels 
with air which is injected over the full length of the bottom 
of the panels. The air is enriched with carbon dioxide (CO2). 
Combustion gases rich in CO2 can also be used. The panels 
are typically 0.5 to 1 m high and the length of a single panel 
row can be many meters. The actual length is determined 
by the rate of mixing of the culture across the length of the 
panel. The individual panels need to be well mixed and/or 
panel length needs to be sufficiently short in order to prevent 
unequal distribution of nutrients and micro-algae. Gassing 
the cultures requires considerable energy, therefore, mixing 
and panel length are important design parameters. 
Figure 5 provides a schematic representation of multiple 
vertical panels making up a larger scale production plant. 
The gas leaving the system can be partly recycled in order 
to increase the residence time of the gas bubbles allowing a 
more efficient use of the carbon dioxide supplied.
Despite the need for substantial gassing, the micro-algae 
culture itself does not have to flow as fast as in a tubular 
system where the culture needs to be pumped through the 
degassing vessel and back at a high rate. For this reason, 
the energy requirement for mixing is generally lower in 
panel reactors. However, scale-up in these systems is more 
complicated. 
The panel reactors currently running are pilot scale systems 
that only occupies a few tens of m2 of ground surface as 
illustrated by Figure 6. On the right, Figure 6 shows the so-
called Proviapt system of the Belgian company Proviron. It 
is constituted by big plastic bags filled with water in which 
separate panel structures with a depth of about 1 cm are 
the algae growth chambers. This system is very promising 
since it can be produced in an automated way, based on 
cheap flexible plastic films. Future applied research will 
provide more data regarding the maximal unit size of panel 
photobioreactors and their scalability. Figure 6 on the left, 
shows the so-called green wall developed by the University 
of Florence, which present a design based on deeper and 
higher panels for use at high latitude locations. It can be 
composed of 2 panels per metre with a depth of 5 cm and a 
height of 1 m. These systems based on cheap flexible plastic 
films are not 100 per cent closed and are often referred to 
as semi-closed systems and as the best option to produce 
biomass for food and feed. Closed systems (e.g. tubular 
photobioreactors) are relatively too expensive for this type 
of applications.
Figure 5  Simplified scheme of a vertical panel photobioreactor
Source: Wageningen UR
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In Europe several companies are using or developing closed 
systems for micro-algae growth. The scale is still small (the 
largest plant’s total surface is 1 ha) but many developments 
have taken place in recent years aiming at increasing the 
scale of production and industrialising the field. Examples 
of these companies are: Ecoduna in Austria with rigid flat 
panels (www.ecoduna.com); Phytolutions in Germany (www.
phytolutions.com), Archimede Ricerche in Italy   (www.
archimedericerche.com) and Proviron in Belgium (www.
proviron.com). All these companies use thin plastic films flat 
panels. Tubular photobioreactors are used by the Spanish 
companies AlgaEnergy (www.algaenergy.es), Algasol (www.
algasol.com) and Fitoplancton Marino (www.easyalgae.com), 
by Roquette in Germany (www.roquette.com) and A4F in 
Portugal (www.a4f.pt). The last two companies represent the 
largest production plants in Europe, ca 1 hectare (the plant 
from Roquette is inside a greenhouse while the plant from 
A4F is outdoor).
Southern Europe and Northern Africa are the best locations for 
producing micro-algae biomass due to the solar conditions, 
but only in cases where there is sufficient fertiliser and close 
proximity to CO2 sources. Wastewater from urban or industrial 
activities can be used as a source of nutrients (nitrogen and 
phosphor) for micro-algae production. Flue and fermentation 
gases can be used as CO2 sources. At the moment, it can be 
seen that in this field technology development takes place all 
over Europe, however, large-scale sustainable production is 
likely to take place mainly in South Europe.
2.3 Indoor production systems
2.3.1 Small scale for research
For small-scale algae production - mostly for research 
purposes - a wide range of systems is used. Algae can be 
cultivated in simple Erlenmeyers, in fermenters (photo-
bioreactors) and in so-called flat panel reactors, among 
other things. Figure 7 shows examples of these systems.
Figure 6  Panel photobioreactors
Source: Wageningen UR
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2.3.2 Heterotrophic production systems
Heterotrophic growth is possible for some micro-algae 
species and products but requires organic matter sources, 
thus increasing its cost and reducing its sustainability.For 
the cultivation of heterotrophic algae (see Section 2.1) steel 
fermenters are used for large-scale production (Figure 8). 
Depending on the size, they are placed indoor or outdoor. 
They are, however, completely contained. Fermenters are for 
instance used for the production of long chain unsaturated 
fatty acids by the heterotrophic algae Crypthecodinium cohnii, 
Schyzochytrium or Ulkenia. Sometimes also Chlorella species 
are cultivated in fermenters for use as a dense inoculum 
or for some specific applications. Based on infrastructure 
and knowledge from industrial biotechnology, heterotrophic 
algae can be cultivated in 100.000 l fermenters and at high 
densities (30 – 100 g/l).
2.4 Growth conditions
The growth conditions in algae production systems are diverse 
and depend very much on algae specific natural conditions. 
Eukaryotic algae are found almost everywhere on earth: in 
the sea, in rivers and lakes, on soils and walls, and in animals 
and plants as symbionts. Well-known symbionts of algae are 
lichens, coral, sea sponges and hydra. Algae are prominent 
in bodies of water, common in terrestrial environments and 
are also found in unusual environments, such as on snow 
and on ice where they can be actively growing [14]. Also 
cyanobacteria can be found in almost every terrestrial and 
aquatic habitat, from oceans to fresh water to bare rock to 
soil. Unlike other bacteria, cyanobacteria are able to perform 
oxygenic photosynthesis, i.e. they use light as an energy 
source for growth.
The growth conditions of algae for industrial production 
also shows a wide range: from dark in steel fermenters 
(heterotrophic) to light in glass or plastic growth systems 
(phototrophic or mixotrophic), from salt (seawater), 
brackish to fresh water. Other factors like pH, temperature, 
nutrients and aeration are of importance for optimal growth. 
Optimisation of culture conditions is an important issue in 
algae research.
Figure 9 presents a number of general parameters dealing 
with conditions for culturing micro-algae, based on the 
FAO “Manual on the Production and Use of Live Food for 
Aquaculture” [15].
Figure 7  Three examples of contained production of algae: Erlenmeyers, fermenters and flat panel reactors
Source: WageningenUR
Figure 8  A 1500 litre steel fermenter at Food & 
Biobased Research, Wageningen UR
Source: WageningenUR
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The major challenges in the cultivation of micro-algae for 
food and feed are: 
• Reduction of production costs of feed;
• Improvement of production technologies for the safety of 
food products; 
• Stability/reliability of large cultures and suitable strains 
avoiding contamination and crash of the cultures. 
According to experts opinion, these challenges are expected 
to be addressed in about 5-7 years time.
2.5 Conclusions 
This chapter has given an overview of the current status 
of micro-algae production systems for those micro-algae 
species and products that are most suited for feed and/
or food applications. A distinction is made between open 
systems (including raceway ponds) and closed systems 
(including photobioreactors).
The technology for the production of micro-algae is still 
immature. Research and development has been done in 
recent years and is continuing on cultivation systems. A leap 
in the development of micro-algae technology is required; on 
a practical level, the scale of production needs to increase 
with a concomitant decrease in the cost of production. 
Nowadays, there are many designs available and work is 
continuing on the improvement of existing systems and 
process strategies and on the development of new concepts. 
Presently, the main challenges are scale-up, reduction of 
production costs and attaining stable and reliable processes.
 
Figure 9  General parameters for algal cultivation
Parameters Range Optimum
Temperature (°C) 16-27 18-24
Salinity (g.l-1) 12-40 20-24
Light intensity (mmol/m2/s) 15-135 (depends on volume and 
density)
40-70
Photoperiod (light: dark, hours) 16:8 (minimum)
24:0 (maximum)
pH 7-9 8.2-8.7
Manual on the Production and Use of Live Food for Aquaculture, FAO [15]
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This chapter concerns the market of microalgae-based 
products: its current situation and future developments. In 
particular, Section 3.1 presents the micro-algae products 
that are currently on the market and in the pipeline, and 
their producers. Section 4.2 illustrates the global market 
figures for micro-algae products, and highlights the main 
producers. Section 3.3 discusses the economic aspects of 
the production process, focusing mainly on cost structures 
of production technologies. Finally, Section 3.4 presents the 
outcomes of a survey and interviews with key experts on 
future developments in micro-algae research and production 
and their driving factors (see Annex B). 
3.1 Products and producers
3.1.1 Food and feed products and their producers 
Traditionally, micro-algae such as Spirulina and Chlorella 
are directly sold as dietary supplements, without any kind 
of processing except drying. The development of these 
products is relatively mature and they are produced by a 
relatively large number of producers. Spirulina production is 
concentrated in Asia and the USA, Chlorella mostly in Asia, 
although both are also produced in a small number of other 
countries with warm climates [83]. Chlorella is now also 
produced in Germany in the Klötze plant [69].
Besides the sales of the whole dried algae, nowadays also 
specific high-value components from micro-algae are being 
produced. In general, micro-algae based molecules are 
less competitive than standard synthetic and traditional 
alternatives. However, some micro-algae based molecules 
have specific advantages over their conventional alternatives 
which make their use commercially viable. For instance, 
from a chemical point of view, synthetic molecules are 
only available in specific isomers, which are generally much 
less effective than natural variants for specific applications, 
such as in infant formula, fish pigment enhancers or dietary 
supplements [87].
Astaxanthin (a carotenoid used as pigment) from dried 
Haematococcus Pluvialis is the most developed product 
in this domain. Astaxanthin is either available as dietary 
supplement (mostly USA-produced), or as food additive. 
Other micro-algal sources of carotenoids are presented in 
Figure 10.
3. Current markets, products and 
future developments for micro-algae
Figure 10  List of carotenoids that are possible to obtain by selected micro-algae
Micro-alga source Active compound
Dunaliella salina β-carotene 
Haematococcus pluvialis Astaxanthin, cantaxanthin, lutein 
Chlorella vulgaris Cantaxanthin, astaxanthin 
Coelastrella striolata var. multistriata Canthaxanthin, astaxanthin, β-carotene 
Scenedesmus almeriensis Lutein, β-carotene
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Figure 11 illustrates the most important high-value 
molecules currently on the market, split into pigments and 
fatty-acids, including a description of products applications 
as presented by the producers, while Figure 12 lists main 
global producers. A relatively large group of companies 
produces β-carotene, a food additive and ingredient, from 
Dunaliella Salina. Although most producers are located in 
Asia or Australia, European multinationals such as BASF 
and DSM have acquired a number of leading producers in 
Australia and the USA. More recently, a selected number of 
producers in Europe and the USA started producing omega-3 
EPA and DHA from micro-algae, to be used for dietary 
supplements or food ingredients. The pigment phycocyanin 
is produced from Spirulina by a small number of companies.
Figure 11  High-value molecules produced with micro-algae 
that reached the food and feed market
Figure 11  High-value molecules produced with micro-algae that reached the food and feed market
High-value 
component Chemical name
Micro-algae 
source
Application (Function/
Nutrient)
Traditional/ 
synthetic 
alternatives
Pigments
β-carotene 
(Pigment/ 
Carotenoid)
1,3,3-Trimethyl-2-[3,7,12,16-
tetramethyl-18-(2,6,6-
trimethylcyclohex-1-en-1-yl)
octadeca-1,3,5,7,9,11,13,15,17-
nonaen-1-yl]cyclohex-1-ene
Dunaliella
Salina
Colourant (food colourant)
Additive for feed 
(provitamin A)
Food supplement 
(provitamin A, anti-
inflammatory effect, 
chemopreventive (not 
proven)
Synthetic form 
(but only all-
trans isomers, 
cis-isomers 
only come 
from natural 
sources)
Astaxanthin 
(Pigment/ 
Carotenoid)
3,3’-dihydroxy-ß-carotene-
4,4’-dione
Haematococcus 
Pluvialis
Feed additive (pigment 
enhancer for fish)
Food supplement (anti-
oxidant, restores UV 
damage)
Synthetic form
Phaffia yeast 
extract
Phycocyanin 
(Phycobili-protein) Protein complex 
Arthrospira 
Porphyridium
Food pigment
Reagents (Fluorescent 
markers)
Synthetic 
pigments
Fatty acids
EPA Eicosapentaenoic acid
Nannochloropsis, 
Phaeodactylum, 
Nitzschia
Food supplement
(omega-3 fatty acid, brain 
development for children, 
cardiovascular health)
Fish oil
DHA Docosahexaenoic acid Schizochrytium, 
Cryptocodinium
Food supplement 
(omega-3 fatty acid, brain 
development for children, 
cardiovascular health)
Fish oil
Adapted from Spolaore [87]
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Products currently on market 
(Form/Application) Producers of current products Micro-algae source
Fo
od
Astaxanthin (Dietary supplement)
Cyanotech (US, Hawaii) [51]
Haematococcus Pluvialis [51][52]
[54][66][67]
EID Parry (India) [53]
Mera Pharma (US/Hawaii) [66]
BioReal (Sweden) [71]
US Nutra (US) / Parry 
Nutraceuticals (India) [74]
Astaxanthin (Food Ingredient/Additive)
AlgaTech (Israel) [65]
Blue Biotech (Germany ) [54]
Fuji Chemicals (Japan) [52]
Mera Pharma (USA/Hawaii) [66]
BioReal (Sweden) [71]
Spirulina (Dietary supplement)
Cyanotech (US, Hawaii) [51]
Spirulina  (algae as product)
Earthrise (US, California) / 
Dainippon (Japan)  [56]
EID Parry (India) [53]/ USA Nutra  
[74]
Blue Biotech (Germany) [54]
Inner Mongolia Biomedical Eng, 
(Mongolia) [55]
Panmol (Australia) [67]
Spirulina Mexicana (Mexico) [67]
Siam Alga Co (Thailand) [67]
Nippon Spirulina (Japan) [67]
Koor Foods Co (Israel) [67]
Nan Pao Resins Chemicals (China) 
[67]
Hainan Simai Pharmacy (China) 
[67]
Myanmar Spirulina (Myanmar) [67]
Blue Continent (NA) [67]
Figure 12  Major products and producers for food and feed
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Products currently on market 
(Form/Application) Producers of current products Micro-algae source
Chlorella (Dietary supplement)
Blue Biotech (Germany) [54]
Chlorella (algae as a product)
Earthrise (US) / Dainippon (Japan) 
[56]
Roquette Kloetze (Germany) [69]
Chlorella Co. (Taiwan)  [67]
Chlorella (Food ingredient) Phycom (Netherlands) Chorella
Other Dietary supplements (Dietary 
Supplement) 
Innova IG (France) [67] Porphyridum (algae as a product
EPA/DHA (omega-3) as dietary 
supplement
Ocean’s Alive (USA) Nannochloropsis
Flora Health (USA) [72] Schizochrytium [67]
EPA/DHA (omega-3) (food ingredient)
Martek/DSM (USA/NL) [55] Chrypthecodinium [55][157]
Blue Biotech (Germany) [54] Nannochloropsis [57]
InnovaIG (France) [67] Odontella [67]
Photonz [75] (New Zealand) (NA)
Xiamen Huison Biotech Co. (China) Schizochrytum [157]
Lonza 2010 [157]  Ulkenia [157]
β-carotene (as additive/vitamin/
colourant)
EID Parry (India) [60]
Dunaliella Salina [67][70]
Cognis Australia/BASF (Australia/
DE) [55]
Betatene/BASF (DE)
Natural Beta Technologies 
(Australia) [62]
Tianjin Lantai Laboratory, China 
[62]
Nature Beta Technologies (Israel) / 
Nikken Sohonsa (Japan) [67]
Aqua Carotene Ltd (Australia) [67]
Pro Algen (India) Biotech [70]
Shaanxi Sciphar Biotechnology Co. 
[67]
DSM [67]
Phycocyanin (colourant)
Blue Biotech (Germany) [54]
Spirulina [75][54]SandaKing (Japan) [75]
DIC Lifetec (Japan) [interview]
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3.1.2 Food and feed products in the pipeline
3.1.2.1 Food and feed products in the pipeline found 
through desk research
Figure 13 shows the micro-algae products in the pipeline 
identified through desk research and their producers. The 
table combines new producers entering existing markets, 
such as sugar producer EID Parry (India) producing EPA/DHA, 
but also first-to-market innovations such as Algalin Flour 
(substitute for other lipids) developed by Solazyme Roquette 
Neutraceuticals [63]. The table also indicates the level of 
development in the pipeline.
Products currently on market 
(Form/Application) Producers of current products Micro-algae source
Fe
ed
Spirulina (Dietary supplements)
Blue Biotech (Germany) [54]
Spirulina [54]
Ocean Nutrition  (Canada)[68]
Chlorella (Dietary supplements)
Blue Biotech (Germany) [54]
Chlorella
Necton (Portugal)
Astaxanthin (Dietary supplement)
Blue Biotech (Germany) [54]
Haematococcus pluvialis [54][71]
BioReal (Sweden) [71]
Biomass for aquaculture (Living algae 
as feed for fish in aquariums)
Blue Biotech (Germany) [54]
Nannochloropsis  [54]
Isochrysis [54]
Necton (Portugal) [157]
Pavlova
Phaeodactylum
Chaetoceros
Skelotenma
Thalassiosira
Tetraselmis [Pulz]
Astaxanthin (Colourant for living fish) Blue biotech (Germany)[54] Haematococcus pluvialis [54]
BioReal (Sweden) [71]
Algaepaste Innovative Aqua (Canada) [72
Nannochloropsis [72]
Isoschrysis [72]
NA =Not available
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3.1.2.2 Food and feed products in the pipeline from sur-
vey response23
Survey respondents (see Section 3.1.2) were asked to 
provide information on pipeline products that they are aware 
of. This information was used to confirm the results from 
the literature review, and add product developments that 
are not yet published but are known by the field experts. 
The experts were asked to classify these products in four 
specified categories:
• Commercialised pipeline: product/innovation that have 
been authorised for production in at least one country, but 
are not yet marketed;
• Regulatory pipeline: product/innovation in the regulatory 
process to be marketed in at least one country;
• Advanced development: product/innovation for which there 
are multiple¬-location field trials and more than one proof 
of concept;
2 Authorised for production, but not yet marketed
3 Multiple proofs of concept, multi-location trials
• Early development: product/innovation for which there is 
only one proof of concept. 
The results are presented in Figure 14. The results roughly 
confirm the developments described above, but also yield 
additional insights. Firstly, more producers are stepping into 
the EPA/DHA, astaxanthin, carotenoids and phycocyanin 
markets. Products in the advanced development stage which 
were not identified in the literature review are fucoxanthin 
(similar to astaxanthin), proteins, β-glucan (a polysaccharide) 
and phycoerithrin (a pigment). Products that are in the early 
development stage include Lutein, but most products in this 
stage are non-food/feed applications. None of the products 
mentioned in the table below is from GM algae, since GM 
algae nowadays are only used at a research stage.
Product Development Stage The number of respondents that have mentioned this product
EPA/DHA Advanced development 21
Aquaculture feed
Early Development - Advanced 
development
10
Proteins Advanced development 10
Astaxanthin Advanced developments 8
Omega-6 oils for nutritional 
applications
Commercialised 7
Animal feed Commercialised 7
Antioxidants Early development 7
Carotenoids Advanced developments 6
Phycocyanin (pigment) Advanced development 5
Figure 14  Pipeline products from the survey
Figure 13  Pipeline products for food and feed (based on desk research)
Products in pipeline Producers Pipeline phase Micro-algae source
Fo
od
EPA/DHA (omega-3) as 
dietary supplements
Seambiotic (Israel) [61]
EID Parry (India) [53]
Commercialised pipeline2 (NA)
Algalin Flour (Lipid 
Additive)
Solazyme Roquette 
Nutraceuticals [63]
Commercialised pipeline (NA)
Phycocyanin (colorant)
EID Parry (India) [53] Commercialised pipeline Spirulina [53]
Inner Mongolia Biomedical 
Eng. (Mongolia) [64]
NA Spirulina [64]
Fe
ed DHA/EPA Omega 3 Seambiotic (Israel) [61] Advanced development3 Nannochlorosis sp. [61]
(NA) = Not available
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3.1.3 Products on the market other than food and feed
Although not the main focus of this study, the desk research 
also included a brief inventory of other micro-algae 
applications than food and feed. Figure 15 shows the main 
products, most of them in the cosmetics market. A small 
number of European (especially French) and USA companies 
dominate the market of micro-algae components that are 
used in skin care products. More niche applications are in 
the life sciences, in which the Dutch chemical company 
DSM has a strong position. There is no indication of market 
parties actively pursuing applications in the pharmaceutical 
sector. 
Product Development Stage The number of respondents that have mentioned this product
Pigments Advanced development/Regulatory 4
Whole biomass Advanced development 4
Fuel Early development 3
Fucoxanthin (comparable to 
Astaxanthin)
Advanced development 2
Cookies holding whole dried micro-
algae
Commercialised 2
Anti-fungal biomass replacing 
pesticides in food production
Early development 1
Phycobiliproteins from blue green 
algae other than Spirulina
Early development 1
Novel bioreactors (process) Early development 1
Algae harvesting membranes system 
(process)
Commercialised 1
Bulk oils for food/feed development Early development 1
Feed premix for land farming Early Development 1
Lutein (carotenoid) Early development 1
Enzymes Early development 1
Cosmetics Commercialised 1
Noodles with whole algae Commercialised 1
Anti microbial Early development 1
Terpene Synthase (enzymes producing 
carotenoids)
Early development 1
Probiotica Early development 1
Soil amendments Advanced development 1
Novel carbohydrates Early development 1
Phycoerythrin (pigment) Commercialised 1
Vaccines Advanced development 1
Beta-glucan (polysacharide) Advanced development 1
Extra-cellular polysacharids Advanced development 1
Adjuvants from green chemistry 
(enhancing immunology)
Early development 1
Fatty-acids Advanced development 1
Waxes Early development 1
Resins Early development 1
Source: survey
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3.1.4 Pipeline for products other than food and feed
The most important non-food/feed application of micro-
algae in the pipeline is the production of biofuels. Since there 
is a quite broad range of companies currently developing 
these applications, and given the fact that this is a relatively 
distinct market not related to food and feed, these firms 
have not been included in this analysis [94]. An exception 
was made for the companies Solazyme [77] and Seambiotic 
[61] that are developing biofuel applications but are also 
active in other markets. 
Micro-algae based pharmaceutical products are mentioned 
as promising applications (see for instance Pulz and Gross, 
2004). Our analysis shows that this is only addressed in 
academic research; no concrete indications for products in 
the pipeline have been found.
Figure 16 shows an overview of a small number of other 
micro-algae applications that are in the early development 
stage, notably in cosmetics and niche products serving the 
life science sector. There are early stage developments in 
the pharmaceutical sector by research organisations about 
vaccines and anti-microbial paste. None of these products is 
from GM algae.
Figure 15  Other products and producers
Products currently on market Producers of current products Micro-algae / product from micro-algae
Co
sm
et
ic
s
Personal care skin products
Solazyme (US) + Unilever
Fuji Chemicals [77]
(NA)
Soliance (France) [78] Spirulina 
LVMH (France) [87] Chlorella
Daniel Jouvance (France) [87] (NA)
Algenist /Solazyme (USA, California) 
[79]
‘Alguronic acid’  (trade name 
for a undetermined mix of 
polysaccharides produced by 
micro-algae clogging filters in algae 
cultures)
Anti aging skin product (lipid)
Soliance (FR) [78] Skeletonema costatum
Exsymol S.A.M. (Monaco) [87] Arthropira (Spirulina)
Pentapharm (Switzerland) [87] Nannochloropsis
Dunaliella Salina
Hydrating skin product
Soliance [78] Porphyridium cruentum
Codif (France) [87 Chlorella
Anti – inflammation (peptide) Soliance [78] Phaeodactylum tricornutum
Slimming products Soliance [78] Dysmorphococcus globosus
O
th
er
 p
ro
du
ct
s
Fluorescent protein markers Martek/DSM (NA)
Stable isotope biochemicals Spectra Gases/Martek/DSM [87] (NA)
(NA) = Not available
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3.2 Markets 
Although the total production volume and market size of 
micro-algae in general are still relatively small, they have 
been characterised by high growth since 1999. In 1999, 
global production volumes of micro-algae were estimated 
at only 1000 tonnes dry weight. This has increased to 5,000 
tonnes dry weight representing € 1 bn by 2004 [83], which 
represents a 5-fold increase in five years [87]. In 2011, the 
total production volume has risen to 9,000 tonnes dry weight 
[94]. The value of the global marine biotechnology market 
in 2011, with micro-algae as its main component, was 
estimated at €2.4bn, with an expected yearly growth of 10 
per cent [91]. Note that this volume is still small compared 
to other food commodities. Global wheat production for 
instance is around 700 million tonnes annually 4, 70,000 
times as much. Although some micro-algae applications 
have a long tradition, large-scale commercial production of 
micro-algae can still be considered an infant industry.
Over the past decades, over 75 per cent of the production 
volume of micro-algae was used in the health food market 
as dietary supplements [67]. The algae based high value food 
additives and ingredients such as DHA represent a growing 
market. For instance, Martek’s (now DSM) algae-derived DHA 
is found in 99 per cent of all baby food in the USA [85]. 
Other large companies in the food ingredients market - BASF, 
Unilever and Dow Chemical - have noticed the potential of 
these applications and their associated growth and have 
made major acquisitions. 
4 FAOSTAT figure
Generally, micro-algae are produced for one specific 
application. Multiple component production (or fraction) is 
not yet commercialised. There is no market for the left-over 
biomass after the valuable component – e.g. Astaxanthin - 
has been extracted, given the low volumes that are produced.
Figure 17 shows the most recent information available 
on the different sub-markets of micro-algae(-derived) 
products. Key players are mentioned between brackets in 
cases where the total production volume is dominated by 
these specific producers. The potential market for derived 
product is measured by the market size of synthetic (e.g. 
Astaxanthin) or traditional (e.g. fish oil) alternatives. The 
results clearly show that Spirulina and Chlorella still have 
by far the largest production volumes, but also point to the 
large potential markets for high-value products such as DHA/
EPA, β-carotene and Astaxanthin. In general, the production 
is quite concentrated on a small number of players, except 
for Chlorella production that is distributed across relatively 
many small players. All data are world estimates, and due 
to the opacity of production volumes of individual producers, 
shares for specific countries/regions cannot be deducted. 
Information on the size of the European market is therefore 
not available. The interviewees confirmed that there are no 
independent data on production figures in Europe, but one 
expert estimates Europe’s production share at around 5 per 
cent globally.
Figure 16  Other applications in the pipeline
Products in 
pipeline Producers Pipeline phase Micro-algae source
Cosmetics Suncare product Cyanotech [51] Early development (1 
proof of concept)
(NA)
Other pro-ducts
Dielectric Insulating 
Fluids
Solazyme + Dow 
Chemical [79]
Early development (NA)
Bioplastics Algix (US) [93] Early development (NA)
(NA) = Not Available
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3.3 Micro-algal production costs
5 6
In order to gain better insight on the potential market 
opportunities in micro-algae production, cost structures are 
of high importance. Figure 18 provides recent estimates of 
the cost structure of different technologies currently used for 
micro-algae production. As can be seen, there is substantial 
discrepancy between estimates from different studies. 
Unfortunately, no large-scale comparative cost studies have 
5 tonnes - European tonne, 1 tonne = 1,000 kg
6 ton – US ton, 1 ton = 907.1847 kg
been performed [94], and as such these estimates rely on 
individual examples. 
Currently, three main types of production technologies 
for micro-algae exist: open ponds, horizontal tubular 
photobioreactors (PBRs) and flat panel PBRs (see 2.2 and 
2.3 above). Open ponds require more land, but are generally 
cheaper compared to the other options, since PBRs are still 
relatively inefficient [91]. However, PBRs have a much better 
technical capacity to enhance future yields, since conditions 
can be controlled precisely, in contrast to open-pond systems.
Figure 17  Market figures of micro-algae based products
Current product 
based on micro-
algae 
Production 
volume (tons/
year dry 
weight)
Number of 
producers (key 
players)
Value of 
production 
volume (yearly 
turnover)
European 
share in 
produc-tion 
(%)
Potential 
market 
(synthetic /
traditional 
forms)
Food and feed products: whole dryed micro-algae biomass
Spirulina
5,000 tonnes5/
year (2012) [92]
>15 companies 
(Cyanotech / 
Earthrise) [83]
US $ 40m 
(2005)[83]
(NA)
No synthetic 
alternative
Chlorella 
2,000 tonnes/
year (2003) [92]
> 70 companies
(NA) [83]
US $38m 
(2006)[87]
(NA)
No synthetic 
alternative
Food and feed products: micro-algae components
Astaxanthin (based on 
Hae-ma¬tococcus)
300 tonnes/year 
(2004)[92]
>8 companies 
(Fuji Chemicals, 
Cyanotech)
US $10m 
(2004) [87]
(NA)
US$200m 
(2004) [83]
Phycibiliprotein 
colourants (incl 
phycocyanin)
(NA)
>2 companies 
[83]
(NA) (NA)
> US $ 50m 
(2004) [83]
EPA/DHA (Omega-3 
PFA) (based on 
Chrypthecodinium)
240 tons6/year 
(Martek) (2003) 
[83]
>4 companies 
(Martek/DSM) 
[85]
> US $300m for 
Martek (2004) 
[83]
(NA)
±US 14.39bn  
(2009)[88]
β-Carotene (based 
on Dunaliella Salina, 
Schizochrytium, 
Nannochloropsis)
1,200 tons per 
year (2010) [87]
> 10 companies 
(Cognis/BASF) 
[83]
(NA) (NA)
US $ 285m [83] 
(2012)
Other products
Stable isotope 
biochemicals
(NA)
> 1 company 
(Martek/DSM) 
[87]
> $13m (2006) 
[87]
(NA) (NA)
Skin products (NA) > 4 companies
(Solliance, Solazyme/ 
Unilever)
(NA) (NA) (NA)
Fluorescent protein 
markers
(NA) > 1 company
(Martek DSM) (NA) (NA) (NA)
 * year for which estimation was made, past and future in brackets.   NA = Not Available
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These figures were derived for (theoretical) installations 
of 100 hectares (ha) and 200 ha plant size. Note that in 
reality the largest plant producing Spirulina is only 44 ha 
[83], so actual costs per kg dry weight in current production 
sizes are usually higher. A more realistic estimate of total 
costs per kg dry weight in more typical plant sizes is around 
$8 - $11 [62]. Costs have already come down considerably 
since 2004 [94]. Note that these are average figures with all 
commonly used micro-algae types provided by Norsker et al 
(2010) [92], and the Scenedesmus almeriensis provided by 
Acien [92]. The total production costs of Haematococcus for 
Astaxanthin production is for instance higher than $30 per 
kg dry weight [91]. 
In micro-algae production, economies of scale play a large 
role due the large fixed capital expenditures and minimum-
bound labour costs. This is reflected by a study showing that 
for 1 ha the average cost per kilo dry weight amounts to 
€17.72, for 100 ha this results in an average cost of €4.95 
[92]. It is unclear whether further scale increases would 
result in lower costs, although it is likely to be expected.
When comparing these cost figures for algae biomass with 
other biomass sources, it becomes clear that micro-algae is 
currently far away from being a cheap source of biomass, as 
for instance wheat straw biomass sells for €0.03 per kg [62]. 
For micro-algae-derived products, extraction costs come 
on top of micro-algae production costs. There is hardly any 
information available on the costs of extraction technologies 
in the micro-algae production process. One estimate for oil 
extraction is a cost of around €1.32 per kg (2007) [5]. For 
making pharmagrade (i.e. 99 per cent pure) Astaxanthin, 
expensive extraction techniques are required, which add 
between €10-€15 per kg to the total costs. With conversion 
rates and losses, the total production costs for Astaxanthin 
from micro-algae approaches €465.58/kg.
The use of micro-algae for fuel applications, currently in 
development, is economically difficult: according to recent 
research, near optimal production is required to compete 
with current biomass prices, as for instance palm oil biomass 
is sold for €0.50 per kg [91] [94].
Figure 18  Production costs of micro-algal systems data from different studies
Production 
technology
Capital costs 
per kg Labour per kg
Other variable 
costs (utilities, 
fertilizer) per 
kg
Total costs per 
kg for a large 
(100 ha[92]/ 
200 ha[94]) 
plant
Optimal 
theoretical 
total costs per 
kg dry weight
Open ponds €3.02 [94] €0.15 [94] €1.57 [94]
$25 (2004) [94]
€4.95 [92]
$8 - $11 [62]
€0.68 [92]
€0.21 [62]
Horizontal 
tubular FBR
€2.74 [92]
€9.8 [94]
€0.88 [94]
€0.36 [92]
€0.92 [94]
€1.65 [92]
€4.15 [92]
€12.6 [94]
(NA)
Flat panel FBR €2.01 [92] €0.35 [92] €1.01 [92] €5.96 [92] €1.8 [94]
Figures for 2010/2011. PBR = photobioreactor, NA = Not available
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3.4 Future developments of the 
microalgae-based products for 
food and feed in the EU
This section reports the results of the Delphi-method 
electronic survey that was used to explore the future 
perspectives for the EU, and drivers and constraints for 
research and production. Six of the experts selected for the 
interviews also answered the survey questions. The results 
of this part of the interview have been combined with those 
of the respondents of the electronic survey. 
The results of the Delphi part of the questionnaire (Europe’s 
market position and micro-algae as substitute) are presented 
in sections 4.4.1 and 4.4.2. The results of the questionnaire 
on production costs are presented in section 4.4.3 and those 
on Europe’s competitive position in section 4.4.4.
3.4.1 Market position of EU firms
3.4.1.1 Statement
The introductory text and related statement presented to the 
respondents on Europe’s market position (and on which the 
experts had to answer the questions) are the following: 
Introduction: At the moment there are five micro-algae 
based components and two algae ¬biomass products on the 
food and feed market worldwide. The first category includes 
Astaxanthin, β-carotene, Phycocyanin and two omega-3 
fatty acids (EPA and DHA) and the second Spirulina and 
Chlorella. In the future, micro-algae based proteins and 
oils will also become available as food ingredients. At the 
moment production mainly takes place outside Europe, but 
the market position of Europe-based companies is growing, 
mainly by acquisition. 
Statement: Europe is leader in micro-algae based 
products for the food and feed markets.
The respondents were asked for the time frame in which the 
situation mentioned in the statement will be realised, and for 
the factors that have a positive influence on the achievement 
of the situation described in the statement. 
They could choose a maximum of five from the following list:
− Scientific and technological developments in the field of 
micro-algae research;
− Education and training in the field of micro-algae research;
− Developments in the food and feed market including the 
position of Europe versus other world regions and the 
competition of micro-algae based products with those 
from other sources;
− Intellectual property rights, including patent positions of 
companies in the field;
− Regulation and standards;
− Consumer attitude, referring both to consumer trends such 
as ‘natural’ food, ‘healthy’ food, but also to GM food.
3.4.1.2 First round of results
Figure 19 shows the main results for this statement in the 
first round. Clearly, a large proportion of respondents expects 
that Europe will only become a market-leader in algae based 
products after 2020 (38 per cent). Very few respondents 
believe this will happen before 2016, and a significant 
proportion does not see this happening at all. There is no 
significant difference between levels of expertise, although 
respondents with the highest level of expertise are more 
likely to indicate ‘Never’, and mid-level experts are more 
likely to say ‘After 2020’.
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Looking at positive influential factors, Science & Technology 
and Food and Feed markets are clearly the most important, 
whereas IP and Education and Training are of notably less 
concern, according to the experts. Other positive factors 
mentioned are almost all related to the ‘availability of finance 
and risk capital’. One respondent mentioned the following:
“Europe has many first mover opportunities based on 
the advancements in algae biomass commercialisation 
by European algae technology companies.  This can be 
exploited further, but there needs to be a transition from 
research funded support to commercialisation funding 
support.”
Other respondents commented on the fact that Europe has a 
competitive disadvantage due to strict regulatory standards, 
mainly related to the Novel Foods Regulation:
The only factor why Europe will never be market leader 
is because of the regulatory environment. Novel food 
regulation (and to a lesser extent health claim regulation) 
severely hampers products going to market. So many 
people with good ideas, proven science and production 
models, but getting to market takes too long and costs too 
much money.
The more sceptical respondents, who do not see market 
leadership happen, often refer to the European climate and 
domestic market for algae products:
“[…] Europe has neither the climate for large-scale algae 
production nor the markets to become a world leader.... 
China already produces over 85% of all micro-algae and 
macro-algae biomass produced”.
The interviewed experts stress that a leading market 
position will only be applicable to the high-value molecules 
market, or market control through large multinationals, but 
not local production. Other experts stress that such scenarios 
are generally optimistic (not necessarily unrealistic), but do 
require an increased level of investment, technical solutions 
and entrepreneurship for the statement to be achieved.
3.4.1.3 Second round of results
In the second round (presented in Figure 20), the respondents 
were asked to specify the expected date of achievement 
of the scenario described in the statement. The largest 
group (30 per cent) of the respondents that answered the 
Delphi-questions selected the period 2020-2022 in the 
second round, which confirms the results of the first round. 
A significant share of respondents (22 per cent) believes 
this will already happen in 2016-2018. We also asked what 
driving factor is the most important of all: this is clearly 
Science & Technology.
Figure 19  Europe’s market position (first round)
Technopolis
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3.4.2 Micro-algae based products as substitutes
3.4.2.1 Statement
The introductory text and related statement provided for the 
question about the potential for using micro-algae based 
components as substitutes for synthetic or other natural 
material are the following:
Introduction: Food and feed micro-algae based components 
can be extracted from micro algae biomass, but also from 
other natural sources or they can be synthesised by the 
chemical industry. 
Actual situation at the moment: 
− Astaxanthin: most is produced synthetically; 
− β-carotene growing volumes are produced using micro-
algae, but also extracts from carrots;
− Phycocyanin: mainly from cyanobacteria (blue algae); 
− EPA and DHA: extracted from fish fat and walnuts. 
Statement: Astaxanthin, β-carotene, Phycocyanin, EPA 
and DHA for food and feed applications are mainly 
from algae resources. 
The respondents were asked for the time frame in which the 
situation mentioned in the statement will be realised, and for 
the factors that have a positive influence on the achievement 
of that situation. The respondents could choose from the list 
presented in Annex B.2.2.
Figure 20  Europe’s market position (second round)
Technopolis
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3.4.2.2 First round of results
Figure 21 shows the aggregate results for the questions on 
products substitution in the first round. Most respondents 
expect that high-value components such as EPA/DHA and 
Astaxanthin will be mainly produced from micro-algae 
somewhere between 2016 and 2020, although an almost 
equally large group expects this to happen only after 2020. 
Only 11 per cent of respondents think this situation will 
never arise, although even fewer think that it will happen 
before 2016.
The most important driver is again ‘Science and Technology’, 
chosen by almost 70 per cent of respondents as one of 
the most important factors. Another important factor is 
‘Food & Feed markets’, including market developments of 
alternative competing sources such as mentioned by one of 
the respondents:
“Extraction from fish will become more and more expensive; 
this favours micro-algae”   
‘Regulation and Standards’ and ‘Consumer Attitude’ are 
also relatively important, according to experts. Again, those 
respondents noticing other factors mainly referred to finance 
issues. 
One respondent noted that the trends diverge for Astaxanthin 
and Phycocyanin on the one hand, and EPA/DHA on the other 
hand:
“Astaxanthin and Phycocyanin will mostly come from algae 
in the future. This will not be the case for EPA/DHA, as the 
sheer volume produced world-wide is simply much larger”
Interviewed experts who claim to be very familiar with the 
topic are more sceptical than those claiming to be rather 
familiar, although the difference is not significant. 18 
per cent of those very familiar expect the situation to be 
unachievable, against 7 per cent of those rather familiar. 
In the interviews, one expert indicated that substitution by 
micro-alga based products will increase due to overfishing 
of salmon, leading to higher prices for alternative sources 
of fish oil. More sceptical experts indicate that other bio-
sources are perhaps more competitive than micro-algae, 
such as yeast, fungi and bacteria. 
Figure 21  Micro-algae as substitute for food/feed high-value products (first round)
Technopolis
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3.4.2.3 Second round of results
Figure 22 shows the results of the second Delphi-round 
for the statement on products substitution. The expected 
achievement data converges on the 2020-2022 period, 
with 34 per cent of respondents opting for this choice. For 
this aspect as well, ‘Science and Technology’ is considered 
by the experts as the most important driving factor. The 
‘other’ category mainly includes demand-side factors such 
as market interest in sustainable products and cost of 
alternative biomass sources. 
3.4.3 Production costs
3.4.3.1 Statement
Respondents were asked to name the key challenges that 
need to be addressed for the following statement to be true: 
Introduction: Production costs of micro-algae based 
components for the food and feed market are still relatively 
high, as compared to chemical synthesis or extraction from 
plants of the same components. 
Statement: In 2020, production costs of micro-algae 
based products for the food and feed market are so 
low that in Europe most of these products are now 
micro-algae based. 
Respondents were asked to indicate which technical 
challenges contributed to the achievement of the situation 
in the statement.
They could choose a maximum of five from the following list:
− biomass production technologies;
− harvest technologies;
− extraction technologies;
− up-scaling of production systems;
− component separation technologies;
− product design;
− micro-algal species selection;
− culture stability;
− contamination/ predator invasion/ weed algae invasion;
− quality control monitoring;
− light management;
− other: …….
Figure 22  Micro-algae as substitute for food/feed high-value products (second round)
Technopolis
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In addition they were asked to indicate which non-technical 
challenges contributed to the achievement of the situation 
in the statement.
They could choose a maximum of five from the following list:
− credible product claims of food companies (that use 
micro-algae or their components in their end-products) in 
product advertisements and on the products’ label;
− access to credit by small companies active in the field of 
micro-algae research and production;
− capital investment of large companies in micro-algae 
research and production;
− intellectual property rights;
− personnel trained in micro-algae research and production;
− access to production models that are suitable to micro-
algae production and production of its components;
− lack of public knowledge on the value of micro-algae as 
food and feed product;
− public attitude towards bio-based products referring to 
the discussion in public debates on the use of biomass for 
food or for fuel and related issues such as access of third 
world countries to new agrifood technologies;
− legislation, regulations and standards;
− other: ….. 
3.4.3.2 Results
Figure 23 shows the challenges that respondents think have 
priority to be addressed in order to arrive at the situation 
described in the statement. On the technical side, production 
up-scaling is the main challenge identified by two-thirds of 
the experts involved:
“Key will be to design integrated or large-scale production 
systems to sufficiently reduce costs”
“Production volume is the issue at this moment. Producers 
and customers need to find each other to jointly increase 
market volume up to the point that capacity is not the 
biggest bottleneck.”
On the non-technical side, capital investments, credit access 
and legislation are considered as the main barriers. Other 
factors that were mentioned are the willingness of large 
companies to invest in micro-algal solutions and CO2 pricing 
mechanisms. One respondent also noted that it is important 
to distinguish between the food and feed markets:
“At present, algae companies typically focus on 
supplements (food) rather than feed market due to low 
volumes and high cost of production.  Cost effective scale-
up needed for use of algae as a bulk feed ingredient.”
Figure 23  Challenges in production costs (respondents could choose five challenges for each category)
Technopolis
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3.4.4 Europe’s competitive position
3.4.4.1 Statement
Respondents were asked to identify the most important 
challenges for Europe’s competitive position in industry-
relevant R&D, based on the following statement: 
Introduction: European research groups are very active 
in micro-algae research and the European Commission 
invested in this research field through several framework 
programmes. Also, European industry is increasingly active 
in the field. However, Europe does not have a top position 
(R&D, production) as compared to other world regions. 
Statement: In 2020, Europe’s micro-algae research for 
food and feed applications is fine¬-tuned to the needs of 
European industry and leads to new products and lower costs 
production processes, thereby strengthening the competitive 
position of the European industrial sector in this field. 
The respondents were asked to indicate which key challenges 
contributed to the achievement of the situation in the 
statement.
They could choose a maximum of five from the following list:
− doubling of EC-budgets for micro-algae research;
− technical breakthroughs in micro-algae research; 
− regulatory approval of GM algae based products;
− access to venture capital;
− academic and industrial training in micro-algae research 
and production;
− reduction of biomass production costs; 
− better communication and cooperation between research 
organisations and companies;
− other:……..
3.4.4.2 Results
The results are presented in Figure 24. In order to improve 
Europe’s competitive position in the field of micro-algae R&D, 
cost-reduction and technical breakthroughs are considered 
as the most important challenges by experts. Better co-
operation, especially between academia and industry, is 
considered relevant by around half of the respondents:
“[The Commission should (ed.)] substantially reduce 
investing in R&D at universities and put this into product 
approval teams that put products on the market, safe, 
cheap and fast. Consortia of industry & academia should 
play a key role in this.”
“The European companies should take most more risks 
and should invest much more in R&D.  The link between 
Research and Companies should be improved and 
strengthened”
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3.5 Conclusions
This chapter presents the economic aspects of current micro-
algae production and future developments, focusing on 
factors that can positively contribute to Europe’s competitive 
position in this field in 2020. 
Currently, the most important micro-algal products for the 
food and feed sector are dried micro-algae (such as Spirulina 
and Chlorella), mainly sold directly as dietary supplements. 
These products are relatively mature. Nowadays, specific 
high-value components of micro-algae are also being 
extracted; the most important high-value molecules currently 
on the market are pigments and fatty-acids used as dietary 
supplements. Although most producers of micro-algae for 
food and feed are located in Asia, the USA and Australia, 
European multinationals such as BASF and DSM have 
acquired a number of leading producers in Australia and the 
USA. Analysis of pipeline products show that more producers 
are stepping into the micro-algae components markets. 
Other applications of micro-algae and their components are 
mostly in the cosmetics market. There are no indications of 
market parties actively pursuing micro-algae applications for 
the pharmaceutical sector.
Although the total production volumes and market size of 
micro-algae in general are still relatively small, they have 
been characterised by high and increasing growth rates, from 
1000 tonnes dry weight in 1999 to 9000 tonnes dry weight 
in 2011. Over 75 per cent of the production volume of micro-
algae was for the dietary supplements market; however, also 
the algae-based high-value food additives and ingredients, 
such as DHA, have a growing market. 
There is hardly any public information available about the 
cost structure of the production process (including extraction) 
of micro-algae components from micro-algae. Some data 
are available, but there is substantial discrepancy between 
estimates from different sources.
At the moment micro-algae production takes place mainly 
outside Europe, but the market position of Europe-¬based 
companies is growing (mainly by acquisition). Most experts 
consulted (in the Delphi-survey) estimate that Europe can 
become market leader in micro-algae based products for 
the food and feed markets in 2020-2022. The two most 
important factors that are expected to contribute positively to 
the European market position are scientific and technological 
developments in the field of micro-algae research and in 
the food and feed market. However, experts highlight two 
major factors limiting the European potential: the insufficient 
European domestic demand for these products and the 
Figure 24  Competitive position of Europe
Technopolis
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difficulties in achieving commercial authorization due to 
the Novel Food regulation. Hence, new microalgae-based 
products obtained in Europe will be intended mainly for 
foreign markets.
Many high-value molecular components that can be 
extracted from micro-algae biomass, can also be obtained 
from other natural sources or can be synthesised by the 
chemical industry. Consulted experts expect that high-
value components such as EPA/DHA and Astaxanthin will 
be mainly produced from micro-algae in the period 2020-
2022. The main driving factor is scientific and technological 
development in the field of micro-algae research; others 
include demand-side factors such as market interest in 
sustainable products and high cost of alternative biomass 
sources. 
At present, the low volumes and high production costs of 
microalgae permit exclusively the production of supplements 
and nutrients for human consumption. The microalgae-based 
molecules have specific advantages with respect to their 
synthetic and traditional alternatives that makes their use 
commercially viable for the food sector, despite the higher 
production costs. The higher quality of microalgae-based 
molecules compared to the corresponding alternatives is 
mainly due to their chemical conformation that is much 
more effective for food applications than the syntetic 
variants. However, the bulk production of carbohydrates and 
proteins for the feed sector is not yet forseen in the short 
run, because it would require higher production volumes 
and, consequently, the boosting of the cost effective scale-
up with dramatic reduction of production costs.
Production costs of micro-algae based components for the 
food and feed market are still relatively high in comparison 
to chemical synthesis or extraction from plants. The main 
technical challenge to lower costs of micro-algae production 
is the up-scaling of the production process; while the main 
non-technical challenge is capital investment.
In order to improve Europe’s competitive position in the field 
of micro-algae R&D by 2020, cost reductions, technical 
breakthroughs and better co-operation between academia 
and industry are considered by experts as the most important 
challenges. 
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This chapter provides an overview of the developments in 
biotechnological research and production with emphasis 
on genetically modified (GM) algae. The chapter starts with 
a section on new developments in algae research (4.1), 
continues with a section on research on transgenic algae 
(4.2) and closes with the main conclusions (4.3). 
4.1 New developments in algae 
research
4.1.1 Research topics
Since algae are ubiquitous and have a long history of use, 
there is also a long history of research on these organisms. 
The oil crisis in the 1970s, moreover, increased research on 
algae substantially: large research programs were initiated 
on developing micro-algal energy production systems. 
The boost in algal research was generated in particular by 
worries about oil depletion and environmental concerns 
such as climate change, CO2 issues and land use. Technical 
developments like the introduction of new generation 
DNA technologies, which lead to improvements in algal 
genetic modification techniques, have also contributed 
to the expanding of research on algae. Compared to 
the biotechnology of bacteria, yeast and fungi, algal 
biotechnology is a rather young discipline.
Two main fields of biotechnological research on algae can be 
distinguished [see 1, 16]:
• Technological productivity improvement: this includes 
reactor design, process control, harvesting and extraction.
• Strain improvement: this includes strain selection, 
mutagenesis and genetic modification. This aspect is 
discussed in more detail.
Research on algal components (such as carotenes and 
Astaxanthin) and algal biomass for food supplements 
is mostly focused on improving productivity through 
optimisation of production systems, selection of new or 
better strains, optimising growth conditions and optimising 
extraction procedures. 
More recent developments in DNA sequencing techniques, 
systems biology and tools to determine relevant enzymes 
and metabolites opened possibilities for the design and 
engineering of (new) metabolic pathways for the production 
of new algal products like biodiesel, bio-ethanol, bioplastics, 
recombinant proteins and new pharmaceuticals [17, 18, 19]. 
In 2013, the scientific literature presented perspectives 
regarding the benefits of using algae as natural sources of 
functional food ingredients [159], as well as a review on food 
commodities (oils, proteins) obtainable from micro-algae 
[160]. The authors conclude that micro-algae can be used as 
a sustainable source of food supply and a valuable source 
of bioactive compounds [158]. Furthermore, they have a 
great potential as feedstock for food commodities [160] 
(see also Figure 25). During the interviews, some experts 
mentioned the production of high value proteins. However, 
major breakthroughs are required to enable cost effective 
production of food ingredients from micro-algae.
4. Outlook: R&D and prospects 
for micro-algae biotechnology 
and genetic engineering
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Figure 25  Food commodities from micro-algae: overview of key features, which need to be considered to 
enable successful sustainable, cost effective and safe product applications [160].
[160]
4.1.2 Developments in micro-algae research
As mentioned in the previous paragraph, the big boost in algal 
biotechnological research in the past decade has been on 
developing micro-algal energy production systems (see [20]). 
In this paragraph we will briefly describe biotechnological 
developments in energy production systems and in food/
feed applications.
Bioenergy 
Worldwide, research and demonstration programmes 
are being carried out to develop the technology needed 
to expand algal lipid production, from a craft to a major 
industrial process, [21, 13, 22, 17, 23] with the purpose of 
the production of biofuels. 
Research on algae is also an important topic in Europe and 
several algae R&D projects are on-going. In particular, the 
European Commission has financed many research projects 
through its Framework Programmes. An inventory of R&D 
projects related to algae and aquatic biomass was made 
in 2009 in the framework of the Aquafuels project [25]. 
Figure 26 presents the non-food algae projects, based on 
our knowledge of the field. These projects, additional to 
those mentioned in ref [25], are listed in the table from the 
BIOALGAESORB-project information.
Project title Acronym Coordinator / Coordinating country Finances
Biofuel from Algae 
Technologies
BIOFAT
Prof. Mario Tredici, IT and 
Abengoa Bioenergy, ES 
[121]
Project cost: €10. 4m 
Project Funding: €7.3 m
Sustainable Fuels from 
Marine Biomass Project
BIOMARA
Scottish Association for 
Marine Science (SAMS) 
at the Scottish Marine 
Institute  UK [122]
Project costs: €6m
Project funding € 4.9m 
from the INTERREG IVA
Biowaste and Algae 
Knowledge for the 
Production of 2nd 
Generation Biofuels
BIOWALK4BIOFUELS IT [123]
Energetic Algae ENALGAE UK [124]
EnAlgae has received 50 
per cent of its funding 
through the INTERREG IVB 
NWE programme (€7.3m).
Figure 26  Overview of expertise and EU-funded algae projects related to non-food applications
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Project title Acronym Coordinator / Coordinating country Finances
Utilisation of Micro-algae for 
Wastewater Treatment with 
Energy Purposes
ENERBIOALGAE ES [125]
Real Time Non Invasive 
Characterisation and 
Selection of Oil Producing 
Micro-algae at the Single 
Cell Level
FUEL MAKING ALGAE CZ
Project cost: €45,000
Project Funding: €45,000
Marine Algae as Biomass for 
Biofuels
MABFUEL Dr Julie Maguire, IE
Project cost: €1.4m
Project Funding: €1.4m
Renewable Hydrogen from 
Sun and Water
SOLAR-H2
Margareta Uvhagen Antono, 
SE
Biotechnological Exploitation 
of Marine Products and By 
Products
BIOTECMAR
Fabienne Guerard, FR
[126]
Control of Light Use 
Efficiency in Plants and 
Algae  From Light to Harvest
HARVEST
Dr. Jan Dekker, NL
[128]
Project cost: €4.6m
Project Funding: €4.6m
Towards a Better Sunlight 
to Biomass Conversion 
Efficiency in Micro-algae
SUNBIOPATH
Prof. Claire REMACLE, BE 
[129]
Enabling European SMEs to 
Remediate Wastes, Reduce 
GHG Emissions and Produce 
Biofuels via Micro-algae 
Cultivation
BIOALGAESORB
Cato Kjølstad, NoBio - 
Norsk Bioenergiforening NO 
[131]
Development of an algal 
platform for production 
of building blocks for the 
chemical industry and 
their further conversion to 
products
SPLASH
Dr. Maria Barbosa, 
Wageningen, NL [132]
Project cost: €12.1m
Project Funding: €8.9m
A sustainable chain 
for continuous biofuel 
production using micro-
algae as a production 
platform, thereby making 
2nd generation biofuels 
competitive alternatives to 
fossil fuels.
Fuel4Me
Dr. Maria Barbosa, 
Wageningen, NL
This project will 
demonstrate on large scale 
the sustainable production 
of bio-fuels based on low-
cost micro-algae cultures
All-Gas
Federico Salmon, Madrid, 
ES
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Food and feed applications and other specialty 
products
In addition to the food and feed applications mentioned 
above, Ibañez and Cifuentes [159] recently indicated that 
algae are an interesting source of bioactive compounds to be 
used as functional food ingredients or as pharmaceuticals. 
However, several hurdles need to be overcome in order 
to get the information that is needed to make decisions 
about what are feasible applications for food and feed. 
Important research topics include: comprehensive screening 
of bioactive metabolites produced by different marine 
organisms, gene sequencing and characterisation, and 
unravelling the metabolic pathways behind secondary 
metabolites synthesis. Major biotechnological challenges are 
the development of transformation systems for a variety of 
micro-algae (expected to be achieved within 3-5 years for a 
few key species) and improved strain stability.
EU-funded research projects related to value-added food 
products are presented in Figure 27.
In addition to research on value-added food products 
from micro-algae, food safety assessment is also being 
investigated. For some source organisms, we can employ the 
concept of ‘history of safe use’ to assess consumer safety. 
For instance Chlorella species have already been used as 
food supplement in some countries and thus a history of safe 
use is available. Although there is not a complete package 
of information on toxicity of products from Chlorella, there 
is information on some relevant toxicology parameters and 
human consumption trials on this organism were already 
performed [see ref 160]. So, food safety analysis has already 
provided evidence for some of the products and micro-algal 
strains used [160] but more evidence on safety needs to 
be built up (see Chapter 5 for more information on safety 
aspects of micro-algae).
Project title Acronym Coordinator / Coordinating country Finances
Demonstration of 
integrated and sustainable 
enclosed raceway and 
photobioreactor micro-algae 
cultivation with biodiesel 
production and validation.
INTESUSAL
Wilton Centre, Wilton, 
Redcar, UK
Harnessing Oxygenic 
Photosynthesis for 
Sustainable Energy 
Production
HOPSEP
Prof. Nathan Nelson, Tel 
Aviv, IL
Pilot scale algal research 
centre (including lipid 
production) Relevant to 
Biology & Botechnology, 
Economic assessment
ALGAEPARC
Dr. M. Barbosa, 
Wageningen,  NL [133]
Modified from: [25], [26]
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4.2 Genetic modification of 
algae
As a result of increased research on eukaryotic algae and 
cyanobacteria (e.g. Spirulina), a large amount of data, 
protocols and publications on the molecular biology of algae 
have become available [1]. 
This section describes the state-of-the-art of research on 
transgenic algae. It presents an overview of the genetically 
transformed algae strains (3.2.1), the DNA delivery methods 
employed (3.2.2) and the targets of genetic modification of 
algae (3.2.3). 
4.2.1 Genetically modified algal strains and their stabil-
ity 
As presented in the COGEM report [1], transformation of 
the cyanobacterium Synechocystis was already reported 
in 1970 [27]. Successful transformation of the green alga 
Chlamydomonas reinhardtii was reported in 1989 [28]. 
C. reinhardtii has become the model species in molecular 
biology of (eukaryotic) algae and is therefore the best one 
Figure 27  Overview of expertise and EU-funded algae projects related to food, feed or pharmaceutical applications
Project title Acronym Objective Coordinator / Coordinating country
Novel algae-based solution 
for CO2 capture and biomass 
production
ALGADISK
The aim of the ALGADISK 
project is to develop 
a modular, scalable, 
and automatic biofilm 
reactor for Algae biomass 
production, with low 
operational and installation 
costs. The reactor will be 
designed to capture CO2 
from industrial emissions 
to produce high value 
organic products.
SPAIN
Genetic Improvement of 
Algae for Value Added 
Products
GIAVAP
The consortium will adapt 
genetic engineering 
techniques to various algal 
strains of economic interest 
focusing on carotenoid and 
PUFA production and the 
over-expression of peptides 
of commercial value
Dori Schneider, ISRAEL 
[127]
Sustainable Production of 
Biologically Active Molecules 
of Marine Based Origin
BAMMBO
BAMMBO will screen and 
identify target marine 
organisms (e.g. bacteria, 
fungi, sponges, micro-
algae, macro-algae and 
yeasts) from diverse global 
locations for potential as 
sustainable producers 
of high–added value 
molecules
Dr. D. Walsh, IRELAND [168}
AlgaeParc
Pilot scale algal research 
centre (including lipid 
production) Relevant to 
Biology & Biotechnology, 
Economic assessment
Research and production 
facility at pilot scale.  
Comparison of different 
production systems
Dr. M. Barbosa, THE 
NETHERLANDS [133]
Oil production with algae Emerald Oils Production of oils for food 
applications
Prof. Dr. R. Wijffels, THE 
NETHERLANDS
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described [28]. Since 1989 successful genetic transformation 
of approximately 30 algal species has been demonstrated [1, 
19, 18 162]. Figure 28 provides an overview of algal species 
that have been genetically modified (as demonstrated by the 
expression of an antibiotic resistance gene, complementation 
of a mutation, or the expression of a reporter gene) and the 
stability of this transformed species (genetic modification of 
specific traits is discussed in Section 4.2). 
Figure 28  Overview of genetically transformed algal species
Species Stability of transformation* Species
Stability of 
transformation*
Chlorophyta Heterokontophyta
Chlamydomonas reinhardtii Stable Laminaria japonica Stable
Chlamydomonas reinhardtii stable (chloroplast) Undaria pinnatifida Stable
Volvox carteri Stable Phaeodactylum tricornutum Stable
Dunaliella salina Stable
Navicula saprophila 
(Fistulifera saprophila)
Stable
Dunaliella viridis Stable Cylindrotheca fusiformis Stable
Haematococcus pluvialis Stable Cyclotella cryptic Stable
Chlorella sorokiniana; Stable Thalassiosira weissflogii Transient
Chlorella kessleri 
(ParaChlorella kessleri)
Stable Nannochloropsis sp. Stable
Chlorella ellipsoidea Stable Dinoflagellates
Chlorella vulgaris transient Amphidinium sp. Stable
Ulva lactuca transient
Symbiodinium 
microadriaticum
Stable
Ostreococcus tauri stable
Rhodophyta Cyanobacteria
Cyanidioschyzon merolae stable
Spirulina platensis 
(Arthrospira platensis)
Stable
Porphyra yezoensis stable / transient Anabaena sp Stable
Porphyra miniata transient Synechocystis sp. Stable
Kappaphycus alvarezii transient Synechococcus Stable
Gracilaria changii transient Nosctoc muscorum Stable
Porphyridium sp stable (chloroplast)
Porphyridium sp stable Euglenids
Gracilaria stable Euglena gracilis stable (chloroplast)
*nuclear transformation unless otherwise mentioned.
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4.2.2 Methods for DNA delivery
Several methods for DNA delivery have been applied 
successfully to micro-algae. These methods include micro-
particle bombardment (or biolistic), cell agitation with 
micro- or macro-particles (e.g. glass beads), protoplast 
transformation with polyethylene glycol, protoplast or whole 
cell transformation by means of electroporation and finally 
Agrobacterium mediated transformation [29]. Cells from 
the late logarithmic growth phase are commonly used for 
transformation. An extensive overview of transformation 
techniques applied to algae was recently presented by Song 
Qin et al. [162] and is depicted below in Figure 29.
Figure 29  Transformation techniques in algae
Methods Characteristics
Agrobacterium tumefaciens 
mediatedgenetic transformation
The efficiency is highly dependent on many elements and this method is 
technically challenging.
Electroporation It has simple procedure, and is used universally to different genera but 
constrained in brown algae.
Biolistic transformation
Exogenous DNA can be introduced into various cells and tissues. Diversified 
vectors can be applied to overcome the genetic background insufficiency of 
the substances. The manipulation is controllable and mature. But it requires 
specialised and high cost equipment.
Glass beads
The procedure is simple and it doesn’t need high cost transgenic equipment. 
But it is constrained in macroalgae due to immature protoplast regeneration 
technology.
Silicon carbon whiskers method
It overcomes the cell wall’s obstruction of exogenous DNA compared to glass 
beads method and is inexpensive. But it requires strict safeguards to avoid the 
inhalation hazard.
Microinjection Whereas it is a highly efficient and low cost method but it has complicated and 
delicate procedure.
Artificial transposon method Exogenous gene could be directionally integrated into receptor’s genome.
Recombinant eukaryotic algal 
Viruses
It has potential application in brown algae but still needs extensive and 
comprehensive fundamental studies.
Trans-conjugation It is mainly in cyanobacteria and rarely used at present.
Natural and induced 
transformation It is mainly in cyanobacteria and rarely used at present.
[162]
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Although cyanobacteria are generally included in micro-
algae studies, they actually are bacteria (see Section 2.1) and 
can be transformed by established techniques for bacteria, 
e.g. by means of electroporation, by conjugative transfer 
of vectors from E. coli [30] and by a natural DNA uptake 
system which is present in Synechocystis sp. PCC 6803 and 
in Thermosynechococcus elongatus [31]. 
In the transformation experiments of algae, a number 
of selectable markers have been shown to be successful 
in obtaining genetically modified strains. Most selection 
systems for these algae have been tested in Chlamydomonas 
reinhardtii because of its prominent position in the eukaryotic 
algae molecular biology. The number of selection markers for 
cyanobacteria exceeds the number of markers for eukaryotic 
algae.
The promoters used to drive gene expression in transgenic 
algae are either homologous promoters, e.g. the Rubisco 
small subunit (RbcS2) and the ubiquitin (Ubi1) promoter, or 
heterologous promoters like CaMV35S and SV40. CaMV35S, 
the cauliflower mosaic virus promoter, is a typical promoter 
for strong expression in higher plants and works well in 
several algal strains, while the SV40, the simian virus 40 
promoter, a polyomavirus promoter, has been shown to work 
in H. pluvialis and in C. reinhardtii [29].
Nuclear transformation of the eukaryotic algae generally 
results in random integration of transgenes. In C. reinhardtii, 
C. merolae and Ostreococcus homologous recombination 
has been achieved for a precise gene integration but the 
frequency is low [18]. Recently, the oil producing algae 
Nannochloropsis sp. was shown to have a high frequency 
of homologous recombination after transformation and 
selection [32]. In contrast, chloroplast transformation often 
results in homologous recombination [33, 34]. Contrary to 
the eukaryotic algae, homologous recombination is easy to 
achieve in cyanobacteria [35]. Moreover, also autonomously 
replicating vectors can be used in the cyanobacteria 
Synechococcus and Synechocystis [36].
RNA silencing by either antisense or RNAi technology has also 
been applied to algae. Several examples of RNA silencing 
and RNAi technology in C. reinhartii have been reviewed by 
Schroda [37] while RNAi has also been applied to Euglena 
gracilis and Phaeodactylum tricornutum and is predicted to 
become a valuable tool in algae genetics [38].
4.2.3 Targets of algal genetic modification
As already discussed previously [1], genetic modification 
as a tool to improve algal performance is more and more 
considered as a necessity to achieve new and economical 
viable production systems (Figure 30) [1, 13, 39, 22, 17, 40]. 
In general, we can distinguish between three types of targets 
for genetic modification of algae:
1. Improvement of photosynthetic efficiency;
2. Improve productivity of selected products;
3. New GM algae products under development.
Improvement of photosynthetic efficiency
This aspect has direct impact on algal productivity and 
consequently is relevant for biomass production for food, 
feed as well as biofuel production. Daylight intensity is most 
of the time above the maximum photosynthetic efficiency 
of algae and therefore growth is reduced, a phenomenon 
known as photoinhibition. Research in this area focuses on 
the light harvesting antenna complex (LHC) [41,8].
Improve productivity of selected products 
The rising market demand for pigments from natural 
sources has promoted large-scale cultivation of micro-algae 
for synthesis of such compounds. Genes encoding enzymes 
that are directly involved in specific carotenoid syntheses 
have been investigated and further development of 
transformation techniques will permit considerable increase 
of carotenoid cellular contents [43]. One example of algae 
transformation with a gene encoding the enzyme phytoene 
desaturase was published in 2006 [44].
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Despite the above developments, a limited number of 
articles on applications of GM algae for food was found in 
reviews of the last five years, and papers of the last two 
years. Ogbonna [161] stated that, although a lot of work 
has been done to increase the contents and composition of 
tocopherols in higher plants through genetic and metabolic 
engineering, work on genetic modification of microorganisms 
for increased tocopherol accumulation is scarce. Tocopherols 
are antioxidants and have been claimed to prevent various 
diseases caused by oxidative stress. Similar conclusions 
can be drawn regarding applications in new functional 
foods [163]. In particular for food and feed applications, 
the development of transgenic algae faces problems and 
challenges, such as competitiveness, public acceptance, 
regulatory issues and biosafety [163]. 
As mentioned earlier in this report, research on lipid 
production has increased in the past decades due to interest 
in developing algal biofuels. Genetic modification is part of 
the strategy to increase lipid production with algae. Target 
genes are lipid biosynthetic genes, lipid storage genes and 
lipid degradation genes. Obviously, the first two categories 
of genes have to be over-expressed while the third category 
of genes should be inhibited [18, 17].
Another interesting aspect of algae biotechnology is the 
modification of lipid characteristics. This could increase 
the quality of the lipids with regards to suitability as diesel 
fuel feedstock but could also make the lipids suitable for 
other applications like food or feed or industrial applications 
[18]7. Genes for this purpose will be identified in the group 
of fatty acid modifying enzymes, such as desaturases and 
thioesterases which have been studied in GM plants in detail 
already for a long time [45, 46].
7 In relation to fatty acid metabolism, within the GIAVAP project [158] scientists cloned 
a DGAT1-like gene (PtDGAT1) from the diatom P. tricornutum. In a yeast expression 
system, PtDGAT1 restored triacylglycerol (TAG), an ester derived from glycerol and 
three fatty acids and lipid body formation), and favoured incorporation of saturated 
fatty acids into TAGs. In this area the increasing interest in the production of specific 
fatty acids, such as the omega-3 fatty acid EPA, for health food applications [164], but 
also DHA can be noted.
Figure 30  New products that have been made by algae through genetic modification.
Product Algae used Reference
Hepatitis B antigen protein (HBsAg) Dunaliella salina [47] 
Human growth hormone (HGH)
Chlorella vulgaris
Chlorella sorokiniana
[48]
Erythropoietin; Human fibronectin 10FN3 and 14FN3; Interferon β; Proinsulin; 
Human vascular endothelial growth factor (VEGF); High mobility group protein 
B1 (HMGB1)
C. reinhardtii [49]
Bovine lactoferricin  (LFB) C. reinhardtii [50] 
Avian and human metallothionein type II; Antigenic peptide P57; Antigenic 
proteins VP19,24,26,28; Foot and mouth disease virus VP1 protein; Anti-
glycoprotein D of herpes simplex virus; Anti-rabbit IgG; Human tumour 
necrosis factor; Bovine mammary-associated serum amyloid; Classical swine 
fever virus E2 viral protein; Human glutamic acid decarboxylase 65; Human 
erythroprotein; Anti-anthrax protective antigen 83 antibody; D2 fibronectin—
binding domain
C. reinhardtii [114] 
Flounder growth hormone (FGH) Synechocystis [115]
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New GM algae products under development 
An emerging field in algae biotechnology is the introduction 
of genes or metabolic pathways in order to produce 
components of economic interest. Figure 30 gives an 
overview of new products that have been made by algae 
through genetic modification with a focus on recombinant 
proteins. The status within the product pipeline, however, is 
unknown.
Micro-algae integrate the advantages of microbes (such as 
rapid growth and ease of culture) with those of higher plants 
in performing post-translational modification of the obtained 
molecules and photosynthesis. However, several obstacles 
currently hinder the development of economically viable 
micro-algal expression systems. These include:
• lack of effective and consistent transformation methods 
for a wide variety of species;
• low or inconsistent recombinant protein yields;
• lack of production systems optimised for large-scale 
growth and harvesting under photoautotrophic conditions 
[116];
• lack of understanding of algal metabolism and regulation. 
Systematic and concerted research efforts that are both 
conventional and engineering-based such as optimisation of 
promoters, regulatory elements and codon usage, as well as 
development of improved photobioreactor culture systems 
will be critical to the success of micro-algal production 
platforms (see review [117]). It is expected that within the 
next 10 years developments in genome mining will offer 
opportunities for steering the metabolism of e.g. high value 
products.
So far, none of the products mentioned above is commercially 
available. However, research on the application of algal 
systems for the production of these molecules is increasing 
[118, 119, 116, 114].
A review of recent research involving engineering of 
cyanobacteria for the production of valuable compounds has 
been published by Ducat et al. [120].
4.3 Conclusions 
Although in recent decades algal biotechnology was mainly 
focused on food and feed (ingredient) applications, current 
research on algae and genetic modification of algae is 
rapidly expanding due to high expectations with respect 
to the production of biofuel, bio-chemicals and other bio-
products by algae. Large investments from governments and 
industries stimulated the research on GM algae [1]. 
The technology for genetic modification of algae is still rather 
immature, and a lot needs to be done before commercial 
production of products from GM algae will take place. 
Within the area of algal biotechnology and genetic 
engineering the main challenges are to improve: 
• Technological productivity which includes reactors design, 
process control, harvesting and extraction in an efficient 
and sustainable way. Such a process may also include 
fractionation of several products of interest via optimised 
biorefinery; 
• Productivity of selected targeted molecules with 
biotechnological means. This includes strain selection, 
mutagenesis and transgenesis. With regard to the latter 
approach, it is important to develop effective and consistent 
transformation methods for a wider variety of micro-algae 
species and obtain high expression of relevant genes and 
products;
• Strain stability: Due to genetic drift of haploid algae, it is 
important to have stable cultures in order to guarantee a 
secure and constant production.
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This chapter deals with the safety of micro-algae products, 
including both whole dried algae products and components of 
micro-algae for food and feed, and the regulation concerning 
their market introduction in Europe and the United States 
of America (USA). Although GM micro-algae did not yet 
reach a commercial phase, the second part of this chapter 
is dedicated to their safety and to regulatory aspects both 
in Europe and the USA, to complete the overview on micro-
algae regulation.
Figure 31 summarises the regulations that apply to the 
whole production chain of micro-algae products: research, 
production and commercialisation of food and feed products, 
including GM-algae. 
5. Safety and regulatory aspects 
of micro-algae food and feed 
applications in Europe and the USA
Figure 31  EU and US regulation concerning research, production and market introduction of micro-algal 
products (including GM micro-algae) for food and feed applications
Europe United States
Research - EC directives 2009/41/EC (contained use of 
GM algae)
- EC directive 2001/18/EC (deliberate release of 
GM algae)
- NIH rDNA Guidelines
- EPA Standards for microbiological practices, 
under the Toxic Substances Control Act (TSCA)
Production - EC directives 2009/41/EC (contained use of 
GM algae)
- EC directive 2001/18/EC (deliberate release of 
GM algae)
- TSCA Environmental Release Application 
(TERA)
- Microbial Commercial Activity Notice (MCAN) 
under TSCA
[- USDA Plant Protection Act]
Market 
introduction
- EC Regulation on Food Safety (EC 178/2002)
- EC Regulation on Novel Foods and Novel Food 
Ingredients (EC 258/97)
- EC Regulation on Genetically Modified Food 
and Feed (EC 1829/2003)
- EC Regulation on traceability and labelling of 
GMOs and of food and feed products produced 
from GMOs (EC 1830/2003)
- EC Regulation on Nutrition and Health claims 
made on foods (EC 1924/2006)
- Food, Drug and Cosmetic Act
- Dietary Supplement Health and Education Act
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5.1 Industrial relevant 
micro-algae and their safety
5.1.1 Industrial micro-algae for food and feed applica-
tions and their safety aspects
Figure 32 provides a list of micro-algae currently used in 
food or feed applications. Some algae have been given the 
GRAS (generally recognised as safe) status by the FDA (Food 
and Drug Administration) of the USA. 
In Europe the EFSA (European Food Safety Authority) is 
requested to assess the safety of any new food and feed 
compound before they are authorized for production and 
commercilization. EFSA’s scientific panels maintain a 
list of biological agents to which the concept of qualified 
presumption of safety (QPS) can be applied. The QPS list 
is reviewed and updated annually by EFSA. Although no 
algae are included in the QPS assessment list of 2012, 
β-carotene from Dunaliella and docosahexaenoic acid 
(DHA) from Crypthecodinium cohnii are already approved as 
food ingredients by EFSA8 and Chlorella and Spirulina are 
commonly sold as food supplements both in the USA and in 
the EU.
8 See: http://www.efsa.europa.eu/fr/efsajournal/doc/1000.pdf
Figure 32  Micro-algae relevant for food/feed applications and their safety aspects where information is 
available
Organism Species Safety aspect Organism Species
Safety 
aspect
Cyanobacteria Spirulina / 
Arthrospira sp.
GRAS
Heterokon-
tophyta Navicula sp. NT
Synechococcus sp. NT Nitzschia dissipata NT
Chlorophyta Tetraselmis sp NT Phaeodactylum 
tricornutum
NT
Chlamydomonas 
reinhardtii
NT
Thalassiosira 
pseudonana
NT
Haematococcus 
pluvialis
NT Odontella aurita NT
Dunaliella sp. NT Skeletonema sp. NT
Chlorococcum sp. NT
Monodus 
subterraneus
NT
Scenedesmus NT Nannochloropsis sp. NT
Desmodesmus sp NT Haptophyta Isochrysis sp. NT
Chlorella sp GRAS Pavlova sp3 NT
Parietochloris incisa NT Dinophyta Crypthecodinium 
cohnii
GRAS
Rhodophyta Porphyridium 
cruentum
GRAS
Adapted from [1]. NT = no toxins known, GRAS = Generally Recognised as Safe
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Certain marine algae produce potent toxins that have 
an impact on human health through consumption of 
contaminated shellfish and finfish and through water or 
aerosol exposure. Toxic algae can be filtered from the water 
by shellfish, such as clams, mussels, oysters, or scallops, 
which then accumulate the algal toxins to levels which 
can be lethal to consumers, including humans [100, 101]. 
Typically, the shellfish are only marginally affected, even 
though a single clam can sometimes contain sufficient toxin 
to kill a human being. Fish and shellfish can also be subject 
to sub-lethal effects, including increased susceptibility to 
disease and reduced growth. Algal toxins can give rise to a 
number of different poisoning syndromes: 
• NSP - neurotoxic shellfish poisoning; 
• PSP - paralytic shellfish poisoning; 
• ASP - amnesic shellfish poisoning; 
• DSP - diarrhoeic shellfish poisoning;
• Ciguatera fish poisoning.
Algae such as Isochrysis, Chaetoceros gracilis, Tetraselmis 
suecica, Pavlova lutheri, Skeletonema costatum, Dunaliella 
tertiolecta, Nannochloropsis sp., Phaeodactylum tricornutum, 
Chlorella sp. that are used in aquaculture or for production of 
food supplements do not produce toxins.
In general, over the past three decades, the frequency 
and global distribution of toxic algal incidents appear to 
have increased, and human intoxications from novel algal 
sources have occurred [99]. Even within the same species, 
large differences exist between toxic and non toxic algae. 
Dinoflagellates and diatoms are best known for their 
production of toxins that can affect humans, but for instance 
the Dinoflagellate strain Crypthecodinium cohnii has a GRAS 
status and is used for commercial production of the omega-3 
fatty acid DHA (134, see Figure 32). Consequently, in view of 
application of algae for food or feed, it is very important to 
know their safety at strain level. The Department of Botany 
of the Smithsonian National Museum of Natural History 
has developed an Internet site with an overview of harmful 
Dinoflagellates and diatoms [104].
5.2 Food safety of human 
consumption of Spirulina
Another example of the importance of knowing the algae 
strains used for human consumption, can be found in 
cyanobacteria. Many of the existing cyanobacteria species 
are known to produce toxins (microcystins, in particular 
MCYST-LR, a small polypeptide that may harm liver function) 
[105], while Spirulina has a GRAS status. An overview of toxin 
producing cyanobacteria can be found on the Cyanosite, an 
Internet site of Purdue University [106]. Although there has 
been no conclusive evidence on the presence or absence of 
microcystins in Spirulina, only products from the blue-green 
algae species Arthrospira platensis have so far been cleared 
for consumption under specific conditions (USA, Australia, 
Canada and EU). 
The case of Spirulina seems to be controversial. A 
Canadian study found that no microcystins was detected 
in cyanobacteria products containing only Spirulina [135], 
while a study conducted for the Oregon Department of 
Agriculture (ODA) published in 2000, found MCYST-LR in all 
the 15 Spirulina samples (dietary supplements) analysed 
[136]. Nevertheless, MCYST-LR content in Spirulina samples 
were below the regulatory level established by the ODA for 
microcystins in blue-green algae products (1 μg/g). 
According to the European legislation, if a product was on 
the market as a food or food ingredient and consumed to 
a significant degree before 15 May 1997, like Arthrospira 
platensis, its access to the market is not subject to the Novel 
Food Regulation (EC) No. 258/97 [167]. However, other 
specific legislation may restrict the placing on the market of 
this product as a food or food ingredient in some EU Member 
States.  
Spirulina has been recognised as GRAS in the USA under the 
“intended conditions of use” implying that it is “for use as an 
ingredient in foods, at levels ranging from 0.5 to 3.0 grams 
per serving”, i.e. in relatively small amounts. Nevertheless, 
considering that safety level and possible hazards for 
consumption of Spirulina and Spirulina-related products have 
not been established beyond doubt, special precautionary 
measures would be necessary on the consumption of 
Spirulina products to some segments of the population at 
risk to include pregnant women, nursing mothers, people in 
dialysis and immune-compromised (see review [137]).
5.3 European regulation on 
marketing of micro-algae for 
food and feed
Three European regulations apply to the marketing of micro-
algae or its components: on food safety, on novel food and 
novel food ingredients, and on nutrition and health claims 
for food. They will be presented in more detail in this section. 
The EU regulation on GM food and feed will be presented in 
Section 5.7.
Regulation on Food Safety 
Market introduction of food products using the whole micro-
algae organisms (such as Spirulina, or Chlorella) or products 
that include the micro-algae (like pasta with the green algae 
colour) are subject to food safety regulations that apply to all 
food products. This is the European Community Regulation on 
Food Safety (EC 178/2002) published in 2002 in the Official 
Journal of the European Communities (1.2.2002 EN L 31/1). 
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This Regulation provides a framework for a coherent approach 
in the development of any food legislation; it provides the 
general framework for those areas not covered by specific 
harmonised rules but where the functioning of the internal 
market is ensured by mutual recognition. It lays down 
definitions, principles and obligations covering all stages of 
food/feed production and distribution. It establishes common 
principles and responsibilities, the means to provide a strong 
science base, efficient organisational arrangements and 
procedures to underpin decision-making in matters of food 
and feed safety. Also it holds down the general principles 
governing food and feed in general, and food and feed 
safety in particular, at Community and national level. The 
regulation applies to all stages of production, processing and 
distribution of food and feed. The regulation also established 
the European Food Safety Authority (EFSA).
According to experts, food safety is an important issue 
in algae-technology and needs particular consideration 
when algae are produced in open-air systems, since they 
proved to be easily subject to contamination from other 
microorganisms.
Regulation on Novel Foods and Novel Food Ingredients
The Food Safety regulation mentioned above states that 
safety concerning food must be proven by a prolonged period 
of consumption. When this condition is not met - i.e. food 
products are new to the market without a history of safe use 
- these products are not authorised on the European market 
[140] without having performed a safety assessment first. 
Only after these products have met the conditions set out in 
the Regulation on Novel Foods and Novel Food Ingredients 
(EC 258/97 [139]), they are authorised to be marketed. This 
Novel Food regulation applies for those foods and food 
ingredients that were not on the European market before 
May 15, 1997. For instance the EPA- and DHA-rich micro-
algal oils have only recently been introduced to the market 
and thus fall under this regulation, despite EPA and DHA have 
a significant history of consumption before May 15, 1997. 
A similar concept applies to colourants from Spirulina. 
Spirulina itself is not a novel food (as it was already on the 
market before 1997). However, Spirulina’s blue colourant, 
extracted from the algae and refined, is a new product 
and thus falls under the Novel Food Law. This implies that 
companies have to provide information on the safety of 
the food product (including results of animals testing), to 
the EFSA before to commercialied the colourant. This risk 
assessment process is usually time consuming and expensive 
and therefore companies argue with the regulators that 
these requirements are too strict 9. 
9 For the law a colourant is an additive. For additives there is Regulation EC 1333/2008. 
Each food colour authorised for use in the European Union is subject to a rigorous 
scientific safety assessment.
The Novel Food Regulation applies to foods and food 
ingredients:
• which present a new or modified primary molecular 
structure;
• which consist of micro-organisms, fungi or algae;
• which consist of or are isolated from plants and ingredients 
isolated from animals;
• whose nutritional value, metabolism or level of undesirable 
substances has been significantly changed by the 
production process.
Important principles applied in this regulation are that novel 
foods and food ingredients must be safe for consumers 
(not being dangerous or nutritionally disadvantageous) and 
properly labelled so as not to mislead consumers. 
Companies which intent to market a novel food or novel 
food ingredient must apply to a national authority for 
authorisation, presenting the scientific information and 
safety assessment report. Authorisation covers conditions 
of use, designation of novel food or novel food ingredient, 
and specification and labelling requirements. The national 
authority establishes if additional assessment is necessary 
or not. If the Commission and EU countries do not object the 
product can be finally authorised. Before the authorisation, 
the Commission asks the Standing Committee on Food Chain 
and Animal Health for an opinion. However, any decision or 
provision concerning a novel food or food ingredient which is 
likely to have an effect on public health must be referred to 
EFSA Scientific Committee for Food. If the assessed products 
are being used exclusively in food supplements, also new 
uses in other foods require authorisation under the Novel 
Food Regulation.
A novel food or ingredient can also be marketed through 
a simplified procedure called “notification” (see Figure 33) 
[174]. This is done when the applicant considers its food 
or ingredient to be ‘substantially equivalent’ to a similar 
product already on the EU market. The applicant applies 
to the European Commission directly or alternatively seeks 
the opinion of a Member State competent authority. The 
applicant must provide scientific evidence that the product 
is substantially equivalent with respect to composition, 
nutritional value, metabolism, intended use and the level 
of undesirable substances contained therein. The company 
notifies the Commission that they are planning to market 
a novel food or ingredient based on the opinion of a 
food assessment body that has established “substantial 
equivalence”. If the novel food or ingredient is likely to affect 
public health, the Commission asks the opinion to the EFSA 
Scientific Committee for Food. See the figure below with a 
list of micro-algae products for which authorisations and 
notifications have been applied in the EU.
S a f e t y  a n d  r e g u l a t o r y  a s p e c t s  o f  m i c r o - a l g a e  f o o d 
a n d  f e e d  a p p l i c a t i o n s  i n  E u r o p e  a n d  t h e  U S A
53
Figure 33  Applications for micro-algae products under EC 258/97: authorisations (last application December 
2012) and notifications (last application April 2012)
Applications Notifications
Food or food ingredients 
and applicant
Application date and 
Status
Food or food ingredients 
and applicant 
Dates for Notification 
and Transmission to 
Member States 
Additional uses of DHA 
(docsahexaenoic acid)-rich 
oil  from micro-algae 
Ulkenia sp. By Nutrinova, 
Germany
15 November 2004
Commission Decision 
2009/777/EC concerning 
the extension of uses of 
algal oil from the micro-
algae Ulkenia sp. as a 
novel food ingredient under 
Regulation (EC) No 258/97 
of the European Parliament 
and of the Council OJ L278 
of 23 October 2009, p. 54
Microalga
Odontella aurita.
Innovalg S.A.R.L.
Bouin, F
9 December 2002,
19 December 2002
DHA-rich algal oil from 
Schizochytrium sp. For 
additional food uses 
By Martek, USA (UK-FSA)
14 January 2008
Commission Decision 
2009/778/EC concerning 
the exten¬sion of uses of 
algal oil from the micro-
algae Schizochytrium sp. 
as a novel food ingredient 
under Regulation (EC) No 
258/97 of the European 
Parliament and of the 
Council OJ L278 of 23 
October 2009 p. 56
DHA (docohexanoic-
acid)-rich microalgal oil 
(DHActive™)
LONZA AG, Basel
Switzerland
10 November 2003
24 December 2003
Tetrasemilis chuii 
(micro-alga) 
By Fitoplancton Marino S.L., 
Spain
26 July 2011
Pending
Capsules with Astaxanthin-
rich Carotenoid 
Oleoresin extracted from 
Haematococcus Pluvialis 
(max 4 mg Astaxanthin/
capsule). 
Herbal Sciences 
International Ltd.Loughton 
Essex, UK for US Nutra, USA
28 June 2004
13 July 2004
Nannochloropsis gaditana 
(micro-alga) 
By Fitoplancton Marino S.L., 
Spain
26 July 2011.
Pending
Astaxanthin in food 
supplements.
Real AB, Gustavsberg, 
Sweden
17 May 2006
22 May 2006
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The Novel Food Regulation contains also specific requirements 
concerning the labelling of novel food and food ingredients 
which are additional to the general European requirements 
on food labelling [141]. The application must mention any 
characteristics (such as composition, nutritional value and 
intended use) and the presence of materials that may affect 
the health of individuals or that give rise to ethical concerns.
As mentioned above, authorisation for marketing of novel 
foods goes through national authorities. However, most 
national food safety authorities do not publicise progress 
in the field of evaluation of applications for novel foods or 
novel food ingredients on their website, with the exception 
of the UK food safety authority (FSA) [142]. The Dutch 
authority only publishes dossiers that have been finalised. 
At the moment, EFSA leads the process of developing a new 
regulation under which EFSA will act as the bundler for all 
these national requests for authorisation.
The Novel Food Regulation was originally set up in order to 
deal with market introduction of GM food. However, in 2003, 
specific regulations for GM food and GM feed (1829/2003 
and 1830/2003) were introduced (see Section 5.7), leaving a 
rather empty Novel Food Regulation, now only dealing with 
the foods that are novel on the EU market since 1997. In 
the regulation on Genetically Modified Organisms (GMOs), 
the technology employed is a main issue being the most 
influential factor making most of the novel foods ‘novel’. 
There is a discussion at the moment in Europe about which 
technologies should and which technologies should not be 
included under the Novel Food Regulation, such as on the 
use of nanotechnology in the processing and ‘formulation’ 
of algae.
Regulation on Nutrition and Health Claims made on Foods
In 2006, the European Regulation on Nutrition and Health 
Claims made on Foods was introduced (Regulation (EC) 
1924/2006 [144]). This regulation states that health claims 
on food/feed products shall be based on and substantiated 
by generally accepted scientific evidence (Article 6). Health 
claims should only be authorised in the EU after a scientific 
assessment of the highest possible standards. In order to 
ensure harmonised scientific assessment of these claims, 
EFSA is carrying out such assessment. 
EFSA Panel on Dietetic Products Nutrition and Allergies 
(NDA) provides scientific opinions on all health claims made 
in food/feed products. The regulation states that scientific 
substantiation should be the main aspect to be taken into 
account for the use of nutrition and health claims and the 
food business operators using claims should justify them. 
A claim should be scientifically substantiated by taking into 
account the totality of the available scientific data and by 
weighing the evidence.
5.4 USA regulation on market 
introduction of micro-algae
Two USA laws are applicable on micro-algae based food and 
feed products once they are sold on the consumer market: 
• the Federal Food, Drug and Cosmetic Act (FD&C) introduced 
in 1938 [152], which regulates all foods and food additives;
DHA and EPA from 
Schizochytrium sp 
By Martek Biosciences, USA
31 January 2011.
No objections may be 
placed on the market 
pursuant to Article 4.2 of 
Regulation (EC) No. 258/97
Food supplements 
with Astaxanthin-rich 
oleoresin extracted from 
Haematococcus Pluvialis.
Cyanotech Corporation USA 
7 March 2007
13 March 2007
Astaxanthin rich extract 
from Haematococcus 
pluvialis.
Alga Technologies Ltd. Is.
14 April 2008
13 May 2008
DHA from
Schizochytrium sp.
Ocean Nutrition Canada 
Limited, Canada
20 April 2012
25 April 2012
[169, 170]
Applications Notifications
Food or food ingredients 
and applicant
Application date and 
Status
Food or food ingredients 
and applicant 
Dates for Notification 
and Transmission to 
Member States 
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• the Dietary Supplement Health and Education Act (DSHEA) 
introduced in 1994, which amended the FD&C Act to cover 
dietary ingredients and supplements. 
The FDA regulates both acts. The FDA Center for Food Safety 
and Applied Nutrition (CFSAN) is responsible for regulating 
food ingredients and ensuring that those ingredients are 
safe and lawful. The authorisation of feed products falls 
under the FDA Center for Veterinary Medicine (CVM).
Food, Drug and Cosmetic Act
The legal status of a food substance depends on whether 
it is used in a conventional food, a dietary supplement or 
as ingredient in a dietary supplement product. For the FDA, 
any substance that is intentionally added to food is a food 
additive and is subject to premarket review and approval by 
FDA, unless the substance is generally recognised, among 
qualified experts, as safe (GRAS) under the conditions of 
its intended use. The assessment of each ingredient and 
each method of producing that ingredient stands on its 
own merits. In case dried Spirulina biomass is approved, it 
does not mean that an extract from Spirulina biomass is 
automatically approved. In case Chlorella is approved as a 
dietary supplement, it does not mean the oil from the same 
Chlorella species is approved [148].
The seven algae based GRAS food ingredients that have 
been reviewed by FDA (in the period 1998 - March 2012) 
are [148]:  
• Micro-algal oil derived from Ulkenia sp. SAM2179;
• Haematococcus pluvialis extract containing Astaxanthin 
esters;
• Algal oil (Schizochytrium sp.);
• Spirulina: the dried biomass of Arthrospira platensis;
• Laminaria japonica broth and extract powder;
• DHASCO is derived from the micro-algal species 
Crypthecodinium cohnii;
• “Calcified seaweed” derived from Phymatolithon calcareum 
or Lithothamnium corrallioides.
Dietary Supplement Health and Education Act 
The Dietary Supplement Health and Education Act (DSHEA), 
introduced in 1994, provides a regulatory framework for 
dietary supplements. It includes provisions establishing 
current good manufacturing procedures, mechanisms for 
pre-market safety notifications of new ingredients, and a 
mechanism for establishing claims used in product labelling 
[154]. 
According to this act, “the dietary supplement or dietary 
ingredient manufacturer is responsible for ensuring that 
a dietary supplement or ingredient is safe before it is 
marketed”. The FDA is responsible for taking action against 
any unsafe dietary supplement product after it reaches the 
market. Generally, manufacturers do not need to register 
their products with the FDA nor to get FDA approval before 
producing or selling dietary supplements. They simply must 
make sure that product label information is truthful and not 
misleading. 
Domestic and foreign companies that manufacture, 
package, label or hold dietary supplements, including those 
involved with testing, quality control, and dietary supplement 
distribution in the USA, must comply with the Dietary 
Supplement Current Good Manufacturing Practices (cGMPS) 
for quality control. In addition, the manufacturer, packer, or 
distributor whose name appears on the label of a dietary 
supplement marketed in the USA is required to submit 
to the FDA a report describing all serious adverse events 
associated with the use of the dietary supplement in the 
USA. The FDA’s other responsibilities include the oversight 
of product information, such as labelling, claims, package 
inserts, website information and accompanying literature 
[154]. 
The FDA has imposed - under the authority of the FD&C Act 
(Title 21 Sections 301–399 of the United States Code) and the 
Public Health Service Act (42 U.S.C § 201 et seq.) - a number 
of regulatory requirements that address quality and safety 
of dietary supplements and claims. Dietary supplements 
must conform with labelling requirements imposed by 
DSHEA as well as other broader labelling amendments such 
as the Nutrition Labelling and Education Act of 1990 (Publ. 
L. 101- 535) and the Food Allergen Labelling and Consumer 
Protection Act of 2004 (Pub. L. 108-282) [155].
When companies want to market new dietary ingredients, 
the Federal Food, Drug and Cosmetic Act requires that the 
manufacturers and distributors notify the FDA about these 
ingredients. The notification must include information that 
is the basis on which manufacturers/distributors have 
concluded that a dietary supplement containing a new dietary 
ingredient will reasonably be expected to be safe under 
the conditions of use recommended or suggested in the 
labelling. The government have different option: determine 
that the product is not GRAS; requiring further information 
for the evaluation; or sending an acknowledgement letter 
confirming that the information provided is adequate. 
For other types of food products, it is optional for companies 
to ask for GRAS status from the FDA. However, since the 
government can ask any time for such a safety assessment, 
companies usually preventively perform it to pre-empt the 
potential request. Dietary ingredients with health claims are 
considered to be a drug, and fall under the drug regulations.
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5.5 Overview of potential risks 
of GM micro-algae for human 
health and the environment
The issue of the biosafety of GM algae has two aspects: 
potential adverse environmental consequences and 
potential harm to human or animal health in case of food/
feed or pharmaceutical applications. For human health risks, 
the biosafety evaluation could refer to the methods applied 
in higher plants to guarantee that they are safe and they 
do not produce toxic substances or allergens [162]. In the 
USA the FDA, and in Europe the EFSA, are responsible for 
this biosafety evaluation. For the environmental risks, Henly 
et al. [166] have published a comprehensive study on risk 
assessment of GM micro-algae for commodity-scale biofuel 
cultivation which is also relevant for other applications. They 
presented a conceptual design of the problem formulating 
stage of risk assessment for escaping GM algae (see Figure 
34). 
Inevitable escape of GM algae from any type of production 
facility is central to each hypothesis. In general, Henly et al. 
[166] predicted that most target GM algal traits are unlikely 
to confer a selective advantage in nature. Therefore, in a 
natural environment, they would rapidly diminish, resulting 
in low but nonzero ecological risk. Genetic and mechanical 
containment, plus conditional matching of GM algal traits to 
unnatural cultivation conditions, would further reduce this 
risk. These hypothetical predictions, however, must be verified 
through rigorous monitoring and mesocosm experiments 10 
to minimise risk and foster public and regulatory acceptance.
The most important aspects of the risk analysis of GM 
micro-algae, including safety aspects, vertical or horizontal 
gene transfer, strain identity, competition with wild types and 
strain fitness, are analysed in the following sections. For a 
detailed overview we refer to reference [1].
10 A mesocosm is an experimental tool that brings a small part of the natural 
environment under controlled conditions. In this way mesocosms provide a link 
between observational field studies that take place in natural environments, but 
without replication, and controlled laboratory experiments that may take place under 
somewhat unnatural conditions.
Figure 34  Conceptual diagram of the problem formulation stage of risk assessment for escaping GM algae
GM, genetically modified; HAB, harmful algal bloom; EDAB, ecosystem disruptive algal bloom; HGT, horizontal gene transfer  [166]
Commercially cultured
GM alga escapes to
surface waters
GM alga dominates
in situ community
(=HAB/EDAB)
GM alga persists at
low density in situ
(low risk)
GM alga dies
in situ (no risk)
HGT to native
organisms
No HGT to native
organisms (no risk)
Insignificant selective
advantage to recipient
(low risk)
Significant selective
advantage to recipient
(low to high risk)
Economic (ecosystem 
services, fisheries, 
recreation) or human 
health (pathogens, 
toxins) impacts
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5.5.1 Potential harmful properties of GM micro-algae
With respect to contained use, the risk assessment is aimed 
at identification of harmful properties of micro-algae due 
to characteristics of the recipient organism, the insert, 
the vector and the resulting properties of GM micro-algae 
and their products with respect to human health and the 
environment. In general, DNA inserted in the recipient algae 
has been characterised. In this respect, the choice of the 
selection marker (e.g. antibiotic resistance) should be taken 
into account.
5.5.2 Transfer of genetic material to other organisms
An important aspect to be addressed in the Environmental 
Risk Assessment (ERA) is the transfer of inserted genetic 
material to other organisms. Therefore, the point of concern 
is called horizontal gene transfer (HGT) and refers to the 
transfer of genetic material from one organism to another, 
which is a natural mechanism. 
In cyanobacteria, HGT has played an important role in 
evolution [107, 108]. Indeed, ~50 per cent of extended 
cyanobacteria gene families putatively have a history of 
HGT, either between cyanobacteria and other phyla, or within 
cyanobacteria, or both. In these bacteria, HGT is a mechanism 
for real time adaptation and for that reason it is considered 
in the risk assessment of GM bacteria.
In eukaryotic algae, HGT has been part of the evolutionary 
development as well. However, in these organisms this is not 
a real time event and poses no additional risk in GMOs. HGT 
from GM plants to prokaryotes has been studied and was 
shown to pose negligible risks [109]. HGT from bacteria has 
also been studied in relation to mechanisms and barriers 
[110] and to risk assessment of GMOs [111].
5.5.3 Identity and taxonomy of GM micro-algae in rela-
tion to risk management
Regarding industrial applications of algae, knowledge of 
the specific identity of the algae strain is essential for two 
reasons: i) for communication and relevant exchange of 
information among researchers and ii) for use and application 
of adequate results by e.g. industry in order to build on 
already established safety data [1]. Establishing the strain 
identity is especially crucial for gathering information for 
risk assessment research. Taxonomists can be considered as 
important service providers in risk assessment also because 
the ‘history of safe use’ of algae (which is an important 
aspect in risk assessment) is only valid where the identity of 
the algae strain is known. 
In particular for food applications, a history of safe use for a 
certain algae implies that production has proven to be safe 
over a longer period of time (this also implies some forms 
of environmental exposure). As mentioned above, when 
collecting knowledge on the safe use, it has to be certain that 
the historical data refer to the same species as the one that 
is intended to be used. Identity and taxonomy are relevant 
because in case the identity is not known, no history of safe 
use can be built. It is recommended to develop the concept 
of GILSP (Good Industrial Large Scale Practice) to be applied 
to algae strains. 
5.5.4 Fitness and mitigation
Fitness is defined here as the ability to exist/survive in 
the surrounding environment. It is expected that the more 
domesticated the strain is and the more adapted to its 
production environment, the harder it is for the strain to 
exist in the wild environment. Technical solutions for making 
algae (and other micro-organisms) unfit to survive outside 
the defined environment include the growing of salt water 
algae in the country or algae that need vitamin B12 for 
survival. If the production system falls out and the algae 
wash away on the land and in the (sweet water) rivers, they 
will not survive. However, this presumption is not very well 
documented. Molecular approaches - such as metagenomics 
- can be used to genetically characterise the (changes in the) 
environment after release of the GM algae [165, 166] 
5.6 European regulation on 
GM-algae
5.6.1 Research11  
In general, all research - including micro-algae research - 
is governed by regulations in the field of good laboratory 
practice. Research on GM algae is governed by the EC 
directives 2009/41/EC and 2001/18/EC; the first deals with 
contained use of GMOs and the second with deliberate 
release into the environment of GMOs. 
• contained use is defined as ‘any activity in which organisms 
are genetically modified or in which such organisms are 
cultured, stored, transported, destroyed, disposed of or 
used in any other way and for which specific containment 
and other protective measures are used to limit their 
contact with the general public and the environment’;
• deliberate release is defined as ‘any intentional introduction 
into the environment of a GMO or a combination of GMOs 
for which no specific containment measures are used to 
limit their contact with, and to provide a high level of 
safety for, the general population and the environment’.
The European directives are implemented in national 
legislation in one or more regulations, in each member state.
11 Based on [1].
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5.6.212 Production 
Regulation concerning production of GM algae depends 
on the type of production system: contained or deliberate 
release. Cultivation of a GMO in a closed system (such as 
photobioreactors) falls under the regulation of contained use 
(Directive 2009/41/EC, Article 2c).
Natural locations (such as open ponds) are considered as 
deliberate release into the environment since there are no 
effective protective measurements to prevent the algae 
from entering the surrounding environment. Since the open 
ponds are not covered, there is contact with the environment 
through the air, which could also be considered as intentional 
introduction into the environment.
In industrial settings, a safety level of MI-I  may be applied to 
the use of micro-organisms. The safety level MI-I is based on 
the concept of Good Industrial Large Scale Practice (GILSP) 
. This concept, already developed in the OECD ‘Blue Book’ 
[138], implies that, if a host organism has a long history of 
safe use in an industrial setting, the same industrial setting 
offers adequate containment for the use of a GMO derived 
from this host organism.
The rules of GILSP can be applied to the use of a GMO if:  
• the host organism is non-pathogenic and has a long history 
of safe use under industrial conditions;
• the GMO is derived from this host organism using a ‘safe’ 
vector (if applicable) and a ‘safe’ insert, and the resulting 
GMO has a reduced fitness in the environment compared 
to the host organism.
The concept of GILSP implies, inter alia, that living organisms 
of a culture grown under GILSP may be released in the 
environment in as much as that is usual also for the host 
organism, since there is still limited practice in algae 
production systems. In the Netherlands, local municipalities 
have granted environmental approval for growth facilities for 
non-modified algae but have done so according to different 
regulations. For example the algae production systems of 
AlgaePARC in Wageningen needed to be contained, while for 
the production systems of Ingepro in Borculo risk assessment 
was required.  
With respect to the European regulation of GM algae applied 
in production system, the COGEM study [1] concluded that:
• Directives 90/219/EEC and 2001/18/EC cover all issues 
related to a risk assessment of GM algae and GM 
cyanobacteria.
• Closed algae production systems could be considered 
contained when placed inside a building. In this case, an 
ERA according to the directive 2009/41/EC is applicable.
12 Based on [1].
• Cultivation of GM algae and GM cyanobacteria in a closed 
system, which is placed outside may be considered under 
the regulation of contained use when it meets the following 
criteria:
− the system has a long history of safe use under GILSP 
conditions for cultivation of the particular host organism;
− the particular GMO is composed of a non-pathogenic host 
organism, a ‘safe’ vector and insert, and the resulting 
GMO has a lower fitness in the environment than the host 
organism, in agreement with the criteria for organisms 
acceptable for use under GILSP (MI-I, in Netherlands 
regulation).
• Cultivation of GM algae and GM cyanobacteria not meeting 
the criteria of GILSP in outdoor closed systems and 
open pond systems will be subject to an environmental 
risk assessment (ERA) in accordance with EC directive 
2001/18/EC.
5.6.3 Consumption
Regulation on GM Food and Feed 
The European food regulations presented above (2002, 
1997) do not cover GMOs for food and feed (and also not 
food additives, flavourings, or extraction solvents). GMOs are 
subject to the Regulation (EC) 1829/2003 [143] on GM Food 
and Feed. This regulation provides the basis for ensuring a 
high level of protection of human life and health, animal 
health and welfare, environment and consumer interests in 
relation to GM food and feed (whilst ensuring the effective 
functioning of the internal market) and holds procedures for 
the authorisation and supervision of GM food and feed and 
provisions for the its labelling (Article 1). 
Regulation on traceability and labelling of GMOs and 
of food and feed products derived from GMOs
The European Regulation (EC) No 1830/2003 [171] concerning 
the traceability and labelling of GMOs and the traceability 
of food and feed products derived from GMOs covers all 
products which consist of GMOs or which contain them, and 
foodstuffs and animal feed products made from GMOs. This 
regulation was made in order to inform consumers through 
compulsory labelling, giving them the freedom to choose 
and to create a “safety net” based on the traceability of 
GMOs at all stages of production and placing on the market. 
This “safety net” will facilitate the monitoring of labelling, 
the surveillance of the potential effects on human health or 
the environment, and the withdrawal of products in case of 
risk to human health or the environment.
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5.7 USA regulation on 
GM-algae
5.7.1 Research
NIH guidelines
The National Institute of Health (NIH) Guidelines for 
Research involving Recombinant DNA Molecules [149] 
apply to biotechnology research that is funded by the 
USA government, including GM algae. R&D conducted 
inside a structure (which might apply to a greenhouse or 
photobioreactor) is expected to follow the NIH guidelines. 
In general, also private companies doing biotech research 
follow these guidelines.
Environmental Protection Agency’s standards for 
microbiological practices
Private companies’ research is regulated by the Environmental 
Protection Agency (EPA) standards for microbiological 
practices. The EPA is in charge of the regulation concerning 
R&D activities; everything before commercialisation is 
assessed by EPA. The Toxic Substances Control Act (TSCA) 
introduced in 1976 provides the EPA with authority to request 
reporting, record-keeping and testing requirements, and 
restrictions relating to chemical substances and/or mixtures. 
The regulation addresses obligations regarding management, 
storage, containment use and disposal of these products. 
Reporting is also required for ‘new’ microorganisms being 
released into the environment and that may be subject to 
a new rule. 
Under TSCA, microorganisms fall under the definition of 
chemical substances, but foods (and pesticides) are excluded 
from this definition. All food products and ingredients are 
treated as food and are exempted from EPA regulation. 
However, GMOs used to produce the food materials are 
not exempted. The EPA requirements concerning microbial 
products subject to TSCA (15 U.S.C. Section 2601, et seq.) 
are set forth in “Microbial Products of Biotechnology; Final 
Regulation under the Toxic Substances Control Act” (62 FR 
17910 (April 11, 1997)) and codified at 40 C.F.R. Part 725. 
This act says, “Microorganisms resulting from the deliberate 
combination of genetic material originally isolated from 
organisms of different taxonomic genera (intergeneric 
microorganisms) constitute “new” microorganisms subject 
to TSCA Section 5 notification requirements”. 
Discussion on interpretation of EPA rules
There is some discussion on the interpretation of the EPA 
rules. Regulation of GM algae in research, pilot plant or in 
production systems depends very much on the nature of the 
reactor in which the organisms would be used. Glass [151] 
concludes on the basis of his experience with authorisation 
for the use of GM algae in biofuel projects that: “If an open-
air algal reactor is (…) judged by EPA not to be sufficiently 
“contained” as defined in the regulations, EPA would consider 
any use of such reactor with live algae to be an outdoor use, 
triggering the need for regulatory oversight (e.g. requiring 
submission of a TSCA Environmental Release Application) at 
the research level and possibly a greater level of scrutiny 
at commercial scale”. He concludes that the regulatory 
situation is not clear yet, but: “With proper planning, advance 
consultation with the Agency (i.e. EPA), and given sufficient 
time to develop the needed data package, algae projects 
that might fall subject to TSCA should not encounter too 
much difficulty in being cleared for commercialization”.
5.7.2 Production 
TSCA Environmental Release Application - TERA
A TSCA Environmental Release Application (TERA) is needed 
for people conducting commercial research and development 
activities, before the initiation of the testing. EPA (following 
the rules set out by TSCA, as introduced above) conducts 
a review of these submissions to determine whether the 
intergeneric microorganisms present an unreasonable risk to 
health or the environment. The Agency can impose regulatory 
controls under Section 5 of TSCA.
The production process with GM algae in open systems has 
had no regulatory history until now. The law is there (a TERA-
approval is needed), but according to one of the interviewees: 
“no one has been bold enough and made an application for 
the cultivation of GM algae in open air”. As soon as such an 
application is being made, FDA will be in charge of it, and 
will consult other agencies (including EPA) about it. But such 
a first application will certainly be accompanied by scrutiny, 
as a new case has to be built about the safety aspects of GM 
algae for the environment.  
For every open pond, a TERA approval is needed and a case-
by-case approval procedure is applied. In the field of GM 
algae the science base has to be built from scratch and will 
take time to be at a level that all necessary information is 
available. A TERA demands extensive information. According 
to the regulation, a company must ask for an approval 60 
days before it aims to start its production but as it takes 
about 6 to 9 months to review, companies apply earlier. 
Especially in the case of a new organism that will be used in 
production (GM algae), this process will take much more time. 
In the period 1998-2007, a total of 17 TERAs submissions 
have been reviewed, of which 14 have been approved (there 
is no information available about the number of TERAs on 
algae). After 2007 there have been no further submissions.
EPA conducts a review of these submissions to determine 
whether the intergeneric microorganisms present an 
unreasonable risk to health or the environment. The agency 
can impose regulatory controls under Section 5 of TSCA. 
This may be applied to outdoor micro-algae raceway pond 
concepts at small- and medium-scale testing facilities. There 
is an exemption concerning R&D for contained use.
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The Animal and Plant Health Inspection Service of the US 
Department of Agriculture (USDA) issues authorisations for 
import, transit and release of regulated animals, animal 
products, veterinary biologics, plants, plant products, pests, 
organisms, soil, and GMOs [172].  
Microbial Commercial Activity Notice - MCAN
People who manufacture, import, or process intergeneric 
microorganisms for commercial purposes subject to EPA 
jurisdiction under the TSCA are required to submit a Microbial 
Commercial Activity Notice (MCAN). MCAN is submitted under 
the biotechnology regulations promulgated under the TSCA 
(62 FR 17910, April 11, 1997; codified at 40 C.F.R. Part 725). 
EPA regulates the use of intergeneric microorganisms 
in commerce or commercial research under the TSCA. 
EPA states that intergeneric microorganisms have a 
sufficiently high likelihood of expressing new traits or new 
combinations of traits to be termed “new” and warrant EPA 
review. The Office of Pollution Prevention and Toxics (OPPT) 
Biotechnology Program conducts a screening program for 
new micro¬organisms under section 5 of TSCA.
The average time spent by a company to prepare a MCAN 
is 8 to 12 months. The review takes EPA about 90 days, 
sometimes more. EPA can either accept the MCAN or inform 
the applicant that he is not yet allowed to start with the 
production and that more information should be provided 
(specified according the questions asked by EPA).
Plant Protection Act 
There is uncertainty about the applicability of the Plant and 
Protection Act (PPA) for micro-algae. At the moment it is not 
applicable, as micro-algae are not a plant or animal pest. 
However, the regulator might at a certain moment decide 
otherwise in case of GM algae. The Animal and Plant Health 
Inspection Services (APHIS) of the USDA regulates certain 
GMOs that may pose a risk to plant or animal health and 
it also participates in programs that use biotechnology to 
identify and control plant and animal pests. It could be 
possible that at a certain moment they also consider GM 
algae (and their new genetic material that could exchange 
with other living creatures) as a pest.
5.8 Conclusions  
This chapter provided an overview on the safety of micro-
algae products in general and GM micro-algae in particular 
and of the most relevant regulations on market introduction 
of micro-algae products and derived products. We discussed 
the regulations in two of the main global markets: the EU 
and the USA, highlighting the directives and acts that rule 
these products.
Regarding the commercial introduction of (non GM) micro-
algae, regulations differe substantially in the EU and USA, 
both in the approach and in the requirements for the 
authorization of micro-algae products. While in the USA the 
regulation applies to the product and assesses if the final 
product is safe or not, the European regulation focuses on 
the technology that is used to obtain the final product.
The most important EU regulations on production and 
marketing of microalgae-based products for food and feed 
are two: the Food Safety Regulation (EC 178/2002) and the 
Novel Food Regulation (EC 258/97). The latter is particularly 
relevant because it provideds the authorization procedures 
for all new food and feed products. Authorization is the first 
and key step for the commercialization of any new food 
and feed product, including the ones from micro-algae, and 
producers must provide all the scientific evidences that new 
products are substantially equivalent to the traditional ones 
in order to be authorized. 
The USDA in its regulation does not make a distinction 
between GM food and non-GM food; any food must be 
safe. In Europe there is additional regulation on food safety 
and labelling of GM food and GM feed (EC 1829/2003 and 
1830/2003). 
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We conclude this report with our findings on Europe’s 
position in the field of micro-algae research and production 
for food and feed applications. First, conclusions are drawn 
on Europe’s position in the field of micro-algae research and 
production (6.1). Second, a number of recommendations is 
being formulated (6.2).
6.1 Conclusions
6.1.1 European strengths in the field of micro-algae 
research and production
Europe’s strengths are its science base, its active R&D 
funding policy and its position in agricultural and industrial 
production and related logistics.
Science and technology base: Europe’s main strength in 
the area of micro-algae applications for food and fuel is 
its strong position in micro-algae science and technology. 
Europe is very active in this field and has good engineering 
and training skills. In addition, Europe has a number of small 
but very R&D-intensive companies that work on technological 
breakthroughs in the field of micro-algae. 
Public R&D funding: This strong position in micro-algae 
science and technology is related to the high priority in R&D 
funding policies in this field of a number of member states 
and of the European Commission. The EC has a focused a 
thematic area in this field in its Framework Programmes and 
active sustainability policies (such as those in Horizon 2020) 
that support scientific and technological developments in 
this field.
Industrial and logistical position: Europe has specific structural 
economic and logistical ‘assets’ that enhance its position 
in micro-algae research and application. Europe has an 
outstanding tradition in high-quality agricultural production 
and a strong food and feed industry with multinationals 
operating on a global scale. An important consumer trend 
is the demand for natural products. Micro-algae based 
applications for food fit into this trend of increased focus on 
healthy eating (omega fatty acids) and sustainably produced 
food. This can further support the position of Europe’s 
food industry. Europe has good physical infrastructure, 
such as large seaports capable of handling large volumes 
of commodities. Europe also benefits from a high level of 
human capital, a workforce with adequate engineering and 
technical skills to work in micro-algae research, development 
and application.
6.1.2 European weaknesses in the field of micro-algae 
research and production
Overall, Europe’s weakness in the field of micro-algae 
research and production for food and feed relates to its 
geographical position, to a number of financial-economic 
aspects, and to its regulation.
Geographical position: Europe’s main weakness with respect 
to the opportunities for micro-algae production is its 
relatively suboptimal climate with high levels of rainfall, low 
levels of sun hours and sun intensity (especially in winter) 
and low temperatures for most countries outside southern 
Europe. For this reason Europe has a lack of surface area for 
the production of micro-algae.
Structural financial-economic disadvantages for Europe are 
its relatively high labour costs, its lack of venture capital 
and seed capital available for start-up companies and low 
entrepreneurial activity among researchers and engineers 
in this field. Due to the focus on public research, there is 
relatively less focus on up-scaling and optimising production. 
Moreover, large companies hardly invest in R&D in this field. 
6. Europe’s position in micro-
algae research and production 
for food and feed: conclusions 
and recommendations
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Also Europe’s relatively high land costs are a weakness when 
it comes to micro-algae production.
Regulation: Further development is also hampered by 
relatively restrictive regulations on GMOs (as compared 
to the USA), and a negative attitude of the public at large 
towards such technologies. Also, Europe lacks a consumer 
history with micro-algae, in contrast with South-East-Asia 
or the USA, which makes effective marketing of micro-algae 
based products more difficult in Europe. 
6.2 Recommendations
There are numerous opportunities and challenges for Europe 
to increase the chance of successful large-scale applications 
of micro-algae in food and feed. These relate to the outputs 
of the high level of R&D in this field (including spill-over 
effects of fuel-related micro-algae research), to the use of 
wastewater streams and to policies.
These opportunities and challenges lead to the following 
recommendations:
• Due to the increasing R&D levels a considerable number 
of new and improved products and production/extraction 
processes are in the pipeline. Competition outside Europe 
is moving fast (China, USA) and in some regions (China, SE 
Asia) there is lack of IP protection. 
• For that reason now is the moment for Europe, given its 
strong position in research in this field and the currently 
still very limited volumes of global production, to explore 
the opportunities for a first-mover advantage in high-
volume high-value processing of micro-algae for food and 
feed. 
• The continuing interest in micro-algae research for fuel 
applications may lead to ‘research spill-over’ in the area 
of food and feed. As the genetic make-up of many algae 
species is not known yet, further research (including into 
genetic modification and that is mostly focussing on 
energy applications) could yield new or more cost-effective 
technologies for food and feed in the future. 
• In order to profit from the ‘spill-overs’ from micro-algae 
based research on bio-fuels, it is recommended to stimulate 
food and feed researchers (public and private) to link-up 
with/get involved in the bio-fuel research programmes.
• In Europe wastewater streams are increasingly well-
organised; these streams are kept separate from other 
water streams, mainly due to environmental regulations. 
The waste water streams hold many components that can 
be used to ‘feed’ the micro-algae.
We recommend the exploration of opportunities for using 
these waste streams as input source in micro-algae 
production. This could become a priority in the EC FP-
programmes.
• We recommend the exploration of the potential of the use 
of a number of European policies for increased sustainable 
development by using opportunities in micro-algae 
research and production. These include:
− A focus in R&D-programmes on co-operation between 
companies (including SMEs) and public research institutes 
could speed up technological breakthroughs and the 
implementation of new technologies . 
− The European Emission Trading Scheme (ETS) could 
provide additional income for micro-algae producers which 
use carbon dioxide as an input. 
− Europe’s efforts on climate change adaptation could lead 
to the use of micro-algae as a diversification strategy for 
food and feed inputs . 
− Europe’s Neighbourhood Policy and our proximity to 
Northern Africa provide opportunities for co-operation in 
efficient micro-algae production. 
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Literature search 
The main source used for the literature search is the database 
Scopus accessed through the website primo.library.wur, that 
is open to students and staff of Wageningen University. In 
addition, further on-line free databases has been searched 
(see below). 
The targets of the literature search were five. For each of 
them a set of keywords and time boundaries has been 
identified and used for the search. Targets and corresponding 
keywords are the following:
1. Production systems: the keywords used for the literature 
search included: “reviews + microalgae”, “reviews + 
microalgae + cultivation”, “reviews + microalgae + 
photobioreactors”. For this topic, material from the master 
course on Marine biotechnology of Wageningen University 
was also used.
2. Economics of micro-algae products and production: the 
literature search employed the following keywords in mixed 
combinations: “microalgae”, “economics”, “production”, 
“price”, “market”, “food”, “feed”, “Astaxanthin”, “EPA”, 
“DHA”, “Beta-carotene”, “Europe”, “Spirulina”, “Chlorella” 
and “company”. Sources from the last seven years were 
included in the analysis. In addition to the Wageningen 
University Library, we made also use of Google Scholar 
and performed an open Internet search. Subsequently, a 
‘snowball strategy’ was used for searching for relevant 
publications and documents that were cited in the 
identified publications.
3. Biotechnology and genetic modification: the keywords 
used for the literature search included “microalgae”, 
“biotechnology”, “food” and the years 2012 and 2013 in 
mixed combinations (previous years were covered in the 
COGEM-report on risks of GM algae [1]). Information on 
traditional food applications of Spirulina was based on 
direct personal knowledge that the authors gathered in 
the last ten years’ experience. Information about European 
research projects was found on the EC Cordis website with 
‘algae’ as search term. Hits for recent projects (from 2011) 
were manually selected for application in food, feed and 
energy.
4. Risks and risk management: the main source of information 
was the recent COGEM-report on risks of GM algae (2012) 
[1]. Moreover, a further literature search on the Internet 
and the Wageningen library system was done using the 
following search terms:  “microalgae” + “risk” + “food” + 
“2012” or “2013”.
5. Regulation: the literature search used the following search 
terms:  “microalgae” + “regulation” + “food”, for the years 
2010-2013. Additionally,  Internet pages of the respective 
governments dealing with the relevant regulations and a 
number of presentations used in conferences were used.
The literature search identified a list of information gaps for 
each of the five topics. These information gaps were filled by 
interviews to experts.
Interviews with key experts 
The interviews to experts were aimed at filling possible 
knowledge gaps identified in the literature search. The 
experts were also asked to revise the chapters of this report 
concerning their field of expertise.
The first step in selecting the experts was to create a long-list 
of stakeholders potentially participating to the interviews and 
survey. Stakeholders’ selection was based on a combination 
of the following characteristics: 
• Having expertees in (at least) one of the following fields: 
micro-algae production systems; economics of the 
production of microalgae-based for food and feed products; 
biotechnology of micro-algae; risks of (GM) micro-algae; 
the European and/or USA regulation on the production and 
use of micro-algae for the food and feed sector.
• Working position, in particular in private or public 
companies or research centers, public institutions or 
regulatory agencies active in the micro-algae field.
• Having produced scientific publications and having 
participated in international conferences in the field of 
microalgae-based food and feed products.
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All the stakeholders identified fulfilling the above 
characteristics constituted a long-list of 219 stakeholders. 
From this list, 18 experts were invited to the interview by 
email. Criteria for selecting the experts for interviews were 
the working position and number of scientific publications. 
Some of them reacted positively, while others declined or 
did not answer at all. All in all 10 experts were interviewed 
(Figure A1). Most of them answered to questions regarding 
only one field, while others’ expertees permitted to answer 
to questions related to two different fields. The experts 
participating to the interviews were also asked to answer 
the survey questions (see next section).
Survey among stakeholders
An electronic survey was used to consult stakeholders and 
experts on the future developments of micro-algae based 
products for the food and feed sectors.
The methodology employed was a combination of a 
standard electronic survey and elements of an expert Delphi 
method. The Delphi approach is a method developed in the 
fifties in the USA for forecasting specific developments. The 
Delphi method is a data collection method based on the 
assessment of possible future developments by selected 
experts who exchange their opinions with the help of a 
written questionnaire. The questionnaire contains a number 
of statements concerning future developments, which have 
to be assessed by a scheme of answering categories. The 
specific feature of the method is that the experts are asked 
to answer the same questions several times. In second (and 
possible subsequent) rounds, the experts are informed about 
the aggregated results of the previous round and are asked 
to review their answers - to the same questions - if necessary. 
The second round thereby serves as a confirmation to 
improve robustness, but also to obtain more specific answers 
compared to the results of first-round. 
In addition to the Delphi-related questions, the electronic 
survey also was used for data collection on a number of 
other topics relevant for this study. 
The Delphi-part of the questionnaire included statements 
and related assessment questions on:
• Europe’s market position in the field of micro-algae: one 
statement, four questions;
• Micro-algae based products as substitutes of traditional 
products: one statement, four questions.
• The other topics addressed in the questionnaire were:
• Production costs: two questions;
• Europe’s competitive position: one question;
• Microalgae products in the pipeline: one question;
• Strengths, weaknesses, opportunities and threats in the 
field of micro-algae: one question. 
The list of questions for the survey can be found in Annex B. 
The interviewed experts were also asked to answer the 
questions of the survey. Six of them did answer the questions.
Figure A1 - List of affiliations, fields of expertees of interviewees, including indication of participation to the 
Delphi survey.
Affiliation
Interview questions Survey 
questionsField 1 Field 2
European Algae Biomass Association / University Florence, It
Production 
systems
University of Almeria, Sp
Production 
systems
Economics x
University of Southampton, UK Economics x
Flemish Institute for Technology (VITO), Flemish Algae 
Platform, B
Economics x
University of Groningen, NL Risks x
University of Cambridge, UK Biotech/GM Risks x
Synthetic Genomics, USA Regulation x
DSM, NL Regulation
DSM, USA Regulation
Medicines Evaluation Board, NL Regulation
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Data collection was carried out via an electronic on-line 
survey tool (SurveyMonkey). The first round was sent on 
March 26th 2013 to a total of 219 stakeholders, 67 of them 
answered the survey. The second round (only for the Delphi-
part of the questionnaire) was sent on April 22nd to the 67 
stakeholders that participated in the first round, while on 
April 26th a reminder was sent to the 139 (206 minus 67) 
stakeholders who did not yet answered to the first round: 
this led to further 21 responses, adding up to a total of 88 
responses. 
A reminder for the second round was sent on April 29th. 
Finally 28 people also answered the Delphi questions for the 
second round.
An overview of the response rates is given in Figure A2. 
Expertise was determined both for market position (first 
figure) and substitution opportunities (second figure).
Annex B presents the list of questions directed to the 
interviewees and the text of the survey.
 
 
Figure A2 - Responses to survey results.
First round Second round
Total target group 219 88
Successful delivery 206 67
Number of respondents 88 28
Response rate 42.7% (88 out of 206) 41.8% (28 out of 67)
Distribution of respondents 
among levels of expertise for the 
question on market position and 
the questions on substitution
Very familiar 48.1% (out of 
88)/38.6% (out of 88)
Rather familiar 48.1% (out of 88)/ 
61.3% (out of 88)
Non-familiar 3.8% (out of 88)/ 4% 
(out of 88)
Very familiar 42.3% (out of 28)/ 
34.6% (out of 28)
Rather familiar 57.7% (out of 28)/ 
65.4% (out of 28)
Non-familiar 0%/ 0%
Distribution of respondents 
between industry, academic/ 
research institutes and other 
experts
Industry 59% (out of 88)
Academia/Research Inst. 32% 
(out of 88)
Other: 9% (out of 88)
Industry 57.1% (out of 28)
Academia/Research Inst. 32.1% 
(out of 28)
Other: 10.7% (out of 28)
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B.1 Specific part: interview 
questions for filling knowledge 
gaps 
Most experts have been asked only the set of questions 
under one of the five headings. Some experts for micro-
algae production systems have also been asked questions 
about economic aspects.
B.1.1   Micro-algae production systems
1. What are the three greatest achievements in the 
cultivation of micro-algae required for implementation 
of micro-algae as a source of food and feed ingredients 
in Europe?
2. When will this be achieved?
3. Which system you believe to be most suitable for algae 
cultivation for food and feed ingredients? Can you 
motivate your choice?
4. In which location do you think the biomass should be 
produced? How can we guarantee enough nutrients on 
site?
5. Do you think it will be possible to use residual streams 
as a source of nutrients for the cultivation of micro-
algae? If yes, which residual streams?
6. What do you think about heterotrophic algae production 
for food and feed ingredients? Will this reach an 
important market share? What are the main advantages/
disadvantages in comparison to autotrophic growth?
B.1.2   Biotechnology/GM of micro-algae
1. What would you consider as the three major 
biotechnological challenges in further development of 
algal products for food applications? 
2. What are future challenges in the field of GM-algae 
research and production in relation to food / feed 
applications. Can you name two challenges?
3. Which breakthroughs do you expect in algal research for 
application in food / feed within 10 years?
4. In your opinion, which GM micro-algae products and 
non-GM micro-algae products are most advanced in the 
pipeline and therefore closer to commercialisation?
5. Do you miss any opportunities or threat?
B.1.3 Economic aspects
1. Could you validate the information currently presented 
in the report? How robust are these figures, especially 
relating to total market size, given that a lot of authors 
cite each other?
2. Could you provide specific figures for Europe?
3. What is the current and future strategy of the 
multinationals that have recently taken over micro-
algae producers in this domain?
4. Are there any new pipeline products not yet identified in 
this chapter? If yes, at which stage they are?
5. What is the current and prospective use of micro-algae 
based ingredients in pharmaceutical products?
6. Do you have any estimates of the cost of harvesting 
Astaxanthin from Haemotococcus?
7. What is the market size of food products derived from 
micro-algae with respect to feed products from micro-
algae? Considering the market size for food and feed 
derived from micro-algae, what is the share for food and 
what for feed? Are they distinct or similar products for 
both markets?
8. What is the market for co-products of micro-algae 
derived products (i.e. dry biomass)?
Annex B Questions for interviews 
and survey
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9. What is the current geographical distribution of micro-
algae production?
10. Do you miss any opportunities and threats (Economic, 
Technical, regulatory, IPR)? Which are most constraining? 
Why?
B.1.4 Risks
1. Are there any potential risks related to the use of micro-
algae isolated from nature in food / feed applications?
2. Are there any potential risks related to the use of GM 
micro-algae in food / feed applications?
3. What would you suggest industry as well as policymakers 
to reduce the risks?
4. Should contained GM-algae in your view be treated 
differently from other GMOs.  And Why?
B.1.5   EU vs USA regulation
1. Is the overview of regulations for micro-algae research, 
production and marketing of micro-algae based products 
food and feed products complete for Europe/USA, What 
is missing? What must be corrected?
2. What is your opinion on the differences between 
European and US regulation?
3. Are you aware of any - other - legislative uncertainty (and 
related discussing between companies and regulators) 
in the field of algae or micro-algae on legislation, 
especially for food and feed in Europe/the USA? 
4. For the USA: Have health claims of micro-algae based 
products been investigated and approved? 
5. Question for national food safety authority: Is Spirulina 
blue colourant an additive or a colourant (or both)? 
Under which regulation does it fall, for each alternative? 
6. How may the current regulation affect the development 
of the micro-algae sector for food and feed, in the EU 
and in the US respectively? In particular, which stage 
may be affected by the regulation: research, production 
or commercialisation?
B.2   General part: Interview and 
survey questions
In the interviews additional questions are asked on the 
background reasons for giving the specific answer (the ‘Why’ 
and “Can you elaborate on your choice / give reasons for 
your choice’ questions).
B.2.1   Europe’s market position (Delphi)
Introduction: At the moment there are five micro-algae 
based components and two algae-biomass products on the 
food and feed market worldwide. The first category includes 
Astaxanthin, β-carotene, Phycocyanin and two omega-3 
fatty acids (EPA and DHA) and the second Spirulina and 
Chlorella. In the future micro-algae based proteins and 
oils will also become available as food ingredients. At the 
moment production mainly takes place outside Europe, but 
the market position of Europe-based companies is growing 
(mainly by acquisition). 
Statement: Europe is market leader in micro-algae based 
products for the food and feed markets.
Question A1: When the situation described in the statement 
will be achieved (tick the one that applies best)? Why?
− Before 2016, 
− Between 2016 and 2020, 
− After 2020, 
− Never.  
Question A2: Which of the following factor(s) have a positive 
influential effect on the achievement of the situation 
described in the statement? Can you motivate your choice?  
− Science & technology,  
− Education & training, 
− Food and feed markets, 
− Intellectual Property, 
− Regulation/standards, 
− Consumer attitude, 
− Other: ….. 
Question A3: How knowledgeable /familiar are you with the 
subject/domain of the statement? 
− Very familiar (in fact I am an expert in the field)
− Rather familiar (I know about it, I am a generalist in many 
fields)
− Non-familiar with specific domain
Question A4: Do you have any comments in addition to your 
answers to the previous questions?
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B.2.2 Micro-algae based products vs other resources 
(Delphi)
Introduction: The five food and feed micro-algae based 
components can be extracted from algae biomass, but also 
from other natural sources or they can be synthesised by the 
chemical industry. 
Actual situation: 
− Astaxanthin: most is produced synthetically; 
− β-carotene growing volumes are produced using micro-
algae, but also extracts from carrots; 
− Phycocyanin: mainly from cyanobacteria (blue-algae); 
− EPA and DHA: extracted from fish fat and walnuts.
Statement: Astaxanthin, β-carotene, phycocyanin, EPA and 
DHA for food and feed applications are mainly from algae-
resources.
Question B1: When the situation described in the statement 
will be achieved (tick the one that applies best)? Why? 
− Before 2016, 
− Between 2016 and 2020, 
− After 2020, 
− Never.  
Question B2: Which of the following factor(s) have a positive 
influential effect on the achievement of the situation 
described in the statement? Can you motivate your choice?  
− Science & technology,  
− Education & training, 
− Food and feed markets, 
− Intellectual Property, 
− Regulation/standards, 
− Consumer attitude, 
− Other: ….. 
Question B3: How knowledgeable /familiar are you with the 
subject/domain of the statement? 
− Very familiar (in fact I am an expert in the field)
− Rather familiar (I know about it, I am a generalist in many 
fields)
− Non-familiar with specific domain
Question B4: Do you have any comments in addition to your 
answers to the previous questions? 
B.2.3 Production costs 
Introduction: production costs of micro-algae based 
components for the food and feed market are still relatively 
high, as compared to chemical synthesis or extraction from 
plants of these components.
Statement: In 2020, production costs of micro-algae based 
products for the food and feed market are that low that in 
Europe most of these products are now micro-algae based.
Question C1: Which of the following technical challenges 
have been addressed and contributed to the achievement of 
the situation in the statement (please pick max 5 challenges)? 
Why these five? Can you elaborate on your choice?
• biomass production;
• harvest;
• extraction;
• scale-up of production systems;
• component separation;
• product design;
• micro-algal species selection;
• culture stability;
• contamination/ predator invasion/ weed algae invasion;
• quality control monitoring;
• light management;
• other: …….
Questions C2: and which of the following non-technical 
challenges? Why these five? Can you elaborate on your 
choice?
• credible product claims ;
• access to capital by small companies;
• capital investment of large companies;
• intellectual property rights;
• trained personnel;
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• access to production models;
• lack of public knowledge;
• public attitude towards biobased products;
• legislation;
• other: …..
B.2.4 Europe’s competitive position
Introduction: European research groups are very active 
in micro-algae research and the European Commission 
invested in this research field through several framework 
programmes. Also the European industry is increasingly 
active in the field. However, Europe has not a top position 
(R&D, production) as compared to other world regions. 
Statement: In 2020, Europe’s micro-algae research for food 
and feed applications is fine-tuned to the needs of European 
industry and leads to new products and lower costs 
production processes thereby strengthening the competitive 
position of the European industrial sector in this field.
Question D: Which of the following key challenges have been 
addressed and contributed to achievement of the situation 
in the statement (please pick max 5 challenges)? Why these 
five? Can you elaborate on your choice?
 
• Doubling of EC-budgets for this type of research;
• Technical breakthroughs; 
• Regulatory approval of GM-algae based products;
• Access to venture capital;
• Academic and industrial training;
• Reduction of biomass production costs; 
• Better communication and cooperation between research 
organisations and companies;
• Other:…….. 
 B.2.5 SWOT analysis of Europe’s position in micro-algae 
research and production
Question E: In your opinion, what are the strengths, 
weaknesses, opportunities and threats of Europe in the field 
of micro-algae research and production, for food and feed 
applications?
Strengths: …. 
Weaknesses: ……
Opportunities: …….
Threats:…. 
B.2.6 Pipeline products
Introduction: So far, the questionnaire focuses on micro-
algae based food and feed products that are already on 
the market. The last question deals with micro-algae based 
products for the food and feed market that are now in the 
pipeline and will be on the market in 2020.
Question F: Which micro-algae based products for the food 
and feed market are now in the pipeline in your university/
research centre/company and are likely to be on the market 
in 2020? Could you for each product indicate in which 
development phase the product is at the moment, choosing 
from the four phases mentioned in the box?
Name Product 1: ………………….     Now in 
development stage: ..
Name Product 2: ………………….     Now in 
development stage: ..
Name Product 3: ………………….     Now in 
development stage: ..
Name Product 4: ………………….     Now in 
development stage: ..
Name Product 5: ………………….     Now in 
development stage: ..
• Commercialised pipeline: product/innovation that have 
been authorised for production in at least one country, 
but are not yet marketed;
• Regulatory pipeline: product/innovation in the regulatory 
process to be marketed in at least one country;
• Advanced development: product/innovation for which 
there are multiple-location field trials and more than 
one proof of concept;
• Early development: product/innovation for which there 
is only one proof of concept.
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